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Abstract
Non-small cell lung cancer (NSCLC) is one of the most diagnosed cancers in Canada, and the
leading cause of cancer deaths. A significant challenge in treating NSCLC is balancing
aggressive treatment with the potentially severe side effects. In radiation therapy, the
management of respiratory motion and the risks of radiation-induced lung injury (RILI) pose
significant challenges. 4-dimensional computed tomography (4D-CT) is an important part of
motion management, but images often suffer from motion-induced artifacts. Volumetric CT
scanners with wide axial field-of-view (aFOV) may reduce these artifacts and present an
opportunity to advance CT-based functional lung imaging.
Chapter 2 presents a phantom imaging study to investigate the suitability of a 256-slice
volumetric CT (vCT) scanner for radiotherapy treatment planning. The density of the highest
density materials was under-estimated by the scanner, which can be addressed with the use of
an appropriate relative electron density (RED) curve. An average RED curve for all aFOV
settings may be used.
Chapter 3 presents a study of phantom and NSCLC patient 4D-CT images acquired on a
clinical scanner and a vCT scanner. The v4D-CT images were re-sampled to simulate a
conventional acquisition using a narrow aFOV clinical scanner. The phantom images
demonstrated that target contouring variability decreased in v4D-CT imaging as compared to
clinical 4D-CT. In the patient images, mean Hausdorff distance between organs at risk (OAR)
contours was significantly correlated to respiratory phase, indicating that motion artifacts
contribute to this variability.
Chapter 4 presents a novel acquisition and analysis pipeline to image lung ventilation (V),
perfusion (Q) and V/Q ratio in a single volumetric CT scan. In a porcine study, these images
of V and Q were significantly correlated to standard Xe-enhanced ventilation and PET
perfusion images in voxel-wise analysis. In a NSCLC patient study, the images were sensitive
to changes in V and Q between baseline imaging and follow-up 6 weeks after radiotherapy.

In this thesis, I demonstrate that volumetric CT scanners are suitable for use in radiation
therapy simulation and treatment planning, and detail two scanning protocols which may
reduce the challenges posed by respiratory motion and RILI risk in NSCLC.

Keywords
X-ray computed tomography, 4-dimensional computed tomography (4D-CT), non-small cell
lung Cancer, functional lung imaging, ventilation imaging, perfusion imaging
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Summary for Lay Audience
Non-small cell lung cancer (NSCLC) is one of the most diagnosed cancers in Canada, and the
leading cause of cancer deaths. Most patients will undergo a combination of therapies which
may include surgery, chemotherapy, radiation therapy, and recently, immunotherapy.
Approximately one in three patients with NSCLC will undergo radiation therapy, which is the
focus of this thesis. When treating this disease, a significant challenge is balancing aggressive
treatment to kill the cancer with the potentially severe side effects. In radiation therapy, the
management of respiratory motion and the risks of radiation-induced lung injury (RILI) pose
significant challenges.
Respiratory motion presents a challenge because patients cannot hold their breath for an entire
radiation therapy delivery, and the motion caused by breathing may cause their tumour to move
during treatment. To give the maximum possible dose to the tumour and protect the
surrounding healthy lungs, this motion must be measured and accounted for in treatment
planning and delivery. 4-dimensional computed tomography (4D-CT) is an essential part of
this process, in which CT images are acquired while the patient breathes freely. Current clinical
CT scanners rely on very consistent patient breathing for this process, which is difficult for
many NSCLC patients. Newer CT scanners with wider detectors may be able to improve these
images.
In Chapter 2, many materials were scanned in the volumetric CT scanner to test its
measurement accuracy. These results showed that the scanner is sufficiently accurate to be
used in radiation treatment planning. In Chapter 3, a moving device was imaged using 4D-CT
on a clinical and volumetric scanner, and four patients with NSCLC were imaged on both
scanners. Analysis of these images showed that the volumetric 4D-CT images more accurately
imaged the respiratory motion of organs in the thorax.
In Chapter 4, we developed and tested a method to image air flow (ventilation) and blood flow
(perfusion) in the lungs using an injected contrast during one volumetric CT scan. The accuracy
of these images was confirmed in an animal study and was demonstrated in two NSCLC
patients before and after radiation therapy.
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CHAPTER 1

1

Introduction

1.1 Motivation and Rationale
Lung cancer is one of the most commonly diagnosed cancers in Canada, estimated to
represent 13% of new cancer diagnoses in 20211. It is also the leading cause of cancer death
in Canada1, as the disease is often very difficult to treat. Lung cancer treatment often
incorporates multiple treatment modalities, and one in three lung cancer patients will
receive radiation therapy as part of their treatment regimen2. This thesis will discuss
patients treated for stage III non-small cell lung cancer (NSCLC), but much of this work is
applicable to treatment of other thoracic cancers. Factors which make effective treatment
difficult in these patients include respiratory motion that must be managed in treatment
planning and delivery, and risk of harmful side-effects due to the radiation dose delivered
to surrounding healthy lung tissue. The latter may lead to radiation-induced lung injury,
which affects approximately 30% of patients who undergo radiation therapy for NSCLC3.
This challenge was highlighted in the results of a multi-institutional randomized trial by
the Radiation Therapy Oncology Group RTOG 06174,5. The aim of the study was to test
the effectiveness of increasing the total treatment dose from 60 Gy to 74 Gy, both in 2 Gy
daily fractions, for patients with advanced NSCLC. The study closed recruitment early
because the high-dose group suffered significantly decreased overall survival (median
survival of 20.3 months in the 74 Gy group, vs 28.7 months in the 60 Gy group, p = 0.004)
with the volume of the heart that receiving ³ 5 Gy significantly associated with increased
risk of death (p = 0.004)4. Subsequent analysis showed that the percentage of lung that
receives ³ 20 Gy was significantly related to the risk of Grade ³ 3 pneumonitis5. These
results highlight the difficulty of delivering a sufficiently high dose to lung tumours without
delivering an unacceptably high dose to the healthy lungs and heart, which may lead to
clinically significant side effects or even premature death.
This thesis will explore some of the technological advances which may be used to improve
accuracy of planning and delivering radiation therapy to moving tumours in the lung. It
1

will focus on the opportunities presented by using a volumetric computed tomography (CT)
scanner for 4-dimensional computed tomography (4D-CT) imaging for treatment planning,
and for functional imaging which may provide clinically valuable information about the
spatial distribution of lung function to minimize the risks of radiation pneumonitis. In this
chapter, the background information necessary to understand and motivate the research
presented in Chapters 2 to 4 will be summarized.

1.2 The Lungs
The lungs are a complex parallel organ which facilitate the delivery of oxygen to the
bloodstream and the removal of carbon dioxide from the blood so it can be exhaled. This
process is called gas exchange. It is achieved through a complex branching structure of
airways and blood vessels which optimize the flow of air and blood to the respiratory
regions of the lungs, where gas exchange takes place, and maximize the cross-sectional
area over which gas exchange occurs. This section will detail the anatomy of the lungs,
define ventilation and perfusion, and how they are measured.

1.2.1

Lung Anatomy

The lungs are made up of branching airways and blood vessels, leading air and blood to
the respiratory zone of the organ where oxygen-rich air and deoxygenated blood pass over
a large surface area of very thin tissue in the alveoli. Gas exchange occurs here, in the
respiratory zone6. The anatomical structure of the lungs is shown in Figure 1-1. The lungs
are surrounded by a thin, smooth membrane called the pleura, and cells which produce
pleural fluid, allowing the outer surface of the lungs to slide against the inner surface of
the chest wall during breathing6.
The airways begin at the mouth and nose, where air is brought in from the environment
and travels down the trachea into the thorax. The trachea bifurcates to form the first
generation of bronchi, with one travelling to each lung. The bronchi continue to bifurcate
approximately 23 times in total, until forming the terminal bronchioles which are less than
1 mm in diameter. The airways from the trachea to the terminal bronchioles form the
conducting zone of the lungs, the function of which is the delivery of air to the respiratory
2

zone. The conducting airways do not contain any alveoli, so they do not participate in gas
exchange. The respiratory zone begins with respiratory bronchioles (which have alveoli on
their walls), alveolar ducts, and finally alveoli. These generations of airways are
collectively called acini, which contain alveoli and are the functional units of the lung6.
The airways from the trachea to the bronchi are structurally supported by cartilage and are
wrapped by smooth muscles which control airway diameter. The bronchioles and
subsequent generations contain no cartilage or smooth muscle and are structurally
supported by the complex network of tissues which make up the acini7.

Figure 1-1 Lung anatomy.
Conducting airways, beginning with the trachea, bifurcate and bring air throughout the
lungs as shown on the left. The terminal bronchiole branches into respiratory bronchioles
which will terminate at alveolar sacs, shown on the right. The alveoli are surrounded by
networks of capillaries, and gas exchange occurs here.
The lungs contain a low-pressure pulmonary blood supply to oxygenate blood from the
right ventricle of the heart, and a high-pressure systemic blood supply to circulate
oxygenated blood to the body from the left ventricle. The pulmonary arteries follow the
same branching structure as the bronchi, forming a network of capillaries surrounding the
alveoli. The walls of the bronchioles and alveoli are extremely thin, made largely of cells
which are specialized to allow gas exchange6.
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1.2.2

Lung Ventilation and Perfusion

Ventilation is the flow of gas into the lungs through breathing, defined as the volume of
gas entering a region per unit time (usually measured in units of L/min). It may describe
total gas flow to the lungs per minute but can also be applied to smaller units within the
lung, such as alveolar ventilation. Perfusion is analogous to ventilation in that it is also a
measurement of flow. Perfusion is defined as the flow of blood through a region per unit
time, and may apply to the lung or to the alveoli6. Air and blood flow through networks of
branching airways and vessels as described above. When they reach the alveoli, they pass
over a large surface area separated by a thin tissue layer across which gas exchange occurs.
The flow of air into and out of the lungs is controlled by the muscles of the thorax which
alter the volume, and therefore the pressure, inside the lungs relative to the atmospheric
pressure outside the body. To inhale, the diaphragm and intercostal muscles between the
ribs contract, causing the diaphragm to move down into the abdomen and the ribs to move
upwards and outwards. This motion increases the volume of the thoracic cavity, causing a
decrease in air pressure inside the lungs. In response to this pressure change, air from
outside the body flows in through the mouth and/or nose, through the conducting airways
and diffuses into the respiratory zone of the lungs. This process is shown in Figure 1-2
below. Oxygen is thus delivered to the respiratory zone, increasing the concentration of
oxygen in the alveoli. The blood passing outside the alveoli has a low concentration of
oxygen, therefore oxygen passes by diffusion across the airway wall and capillary wall into
the blood where it binds to hemoglobin. This diffusion occurs quickly, in approximately
0.25 seconds6.
While oxygen is diffusing into the bloodstream, carbon dioxide is diffusing from the blood
across the blood vessel and alveolar walls into the alveoli because of the low concentration
of carbon dioxide in the alveoli. Passive exhalation is achieved by simply relaxing the
diaphragm and intercostal muscles, so the diaphragm moves up into the thorax and the ribs
move inward and down. This motion is driven by the elastic recoil in the lung structure
itself, which relaxes inward when an external force is not acting to expand it6. As the

4

volume in the thoracic cavity decreases, the pressure increases and air flows from the
alveoli through the conducting airways and out through the mouth and/or nose.

Figure 1-2 The biomechanical process of breathing.
This figure illustrates the mechanical process behind normal breathing. A. At inspiration,
(i) the diaphragm contracts and moves down while (ii) the intercostal muscles contract, (iii)
moving the ribs upwards and outwards. This expands the volume of the thoracic cavity,
decreasing pressure, causing air to flow inward. B. At passive expiration, the (iv)
diaphragm and (v) intercostal muscles relax, and the elastic recoil of the lungs causes them
to contract, (vi) pulling the ribs downwards and inwards. This increases pressure in the
thoracic cavity, causing air to flow outward. Adapted from Young et al8.

1.3 Non-Small Cell Lung Cancer
As stated in Section 1.1, lung cancer is the leading cause of cancer death in Canada2. One
in three patients with non-small cell lung cancer (NSCLC) will undergo radiation therapy
as part of their course of treatment and delivering safe and effective radiation therapy to
the thorax continues to be a challenge. This section and the one following will review the
disease and the types of treatment used, including radiation therapy.

5

1.3.1

The Disease

There are three types of NSCLC: adenocarcinoma, squamous cell carcinoma, and large cell
carcinoma9. Adenocarcinoma is the most diagnosed form of lung cancer, making up
approximately 40% of all lung cancers. It develops primarily in the periphery of the lungs.
Squamous cell carcinoma is the next most common, representing about 20% of lung
cancers. This type of tumour is mainly found in the central lung. Large cell cancers make
up about 10% of lung cancers and will not be discussed in detail here. Small cell lung
cancer will also not be discussed.
Lung cancer is assigned a stage from I to IV based on the size of the lung tumour and the
spread of the cancer in the lungs, lymph nodes, and outside the thorax. Stage I or II cancer
is a tumour of less than 7cm (in most sub-stages, less than 5cm) and is spread only to lymph
nodes near the bronchi10,11. At this early stage, patients will receive surgery if they are
medically eligible, and will likely not receive any radiation therapy. If a patient at this stage
is not able to undergo surgery, they will receive radiation therapy, with most patients
receiving stereotactic ablative body radiotherapy (SABR) unless the tumour is not in a
suitable location9.
If lung cancer has spread to another lobe of the lung, or into further lymph nodes, it may
be classified as stage III10,11 and is commonly referred to as locally advanced NSCLC. At
this stage, nearly all patients will undergo radiation. If the cancer has metastasized to other
regions of the body, it is classified as stage IV, which will not be discussed in detail here.

1.3.2

Treatment of Locally Advanced NSCLC

Most patients diagnosed with stage III NSCLC will undergo radiation therapy as part of
their treatment, which may also include surgery, chemotherapy and/or immunotherapy9,12.
This patient population is very heterogeneous, because the primary tumour or nodal
involvement can vary widely within stage III NSCLC. As a result, many types of treatment
may be considered, and the treatment used often depends on the patient’s health status or
how the patient is expected to tolerate a treatment. The treatment options include radiation
therapy, chemotherapy, immunotherapy, or surgery, any of which may be used alone or in
combination with other treatments9.
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The most common treatment for stage III NSCLC patients who are not good candidates for
surgery is a combination of chemotherapy and radiation therapy9, and immunotherapy is
being used more frequently in this group. While this thesis is focused on imaging for use
in radiation therapy, it is important to consider the other treatments patients will undergo.
While this combination of treatments has been shown to be the most effective for these
patients13,14, it also increases the risk of side effects such as radiation pneumonitis as
compared to single-modality treatment3.

1.4 Radiation Therapy Planning and Delivery
Radiation therapy for NSCLC is delivered using high energy x-rays delivered by a linear
accelerator. The patient lies on a treatment bed, and the linear accelerator rotates around
the patient to deliver radiation from multiple angles around the body. This allows the dose
to the skin and healthy tissues to be kept low, while the beams overlap on the tumour and
add up to deliver a large dose where it is needed. This section of the thesis will outline the
process by which a NSCLC patient’s radiation treatment is planned and delivered.

1.4.1

CT Simulation

In Canada, all patients who will undergo radiation therapy for NSCLC undergo 4D-CT
scanning which is used to simulate radiation treatment delivery12. The process by which
the 4D-CT is acquired is detailed in Section 1.7.1. The 4D-CT dataset is assessed to
determine the magnitude of tumour motion, which informs the medical physicist and
radiation oncologist on what (if any) motion management techniques are needed when
treating the patient15. These techniques are discussed in greater detail in Section 1.5.1. If a
free-breathing method is used, the 4D-CT scan will be appropriate for treatment planning.
Otherwise, additional imaging must be acquired so treatment planning is performed using
imaging that reflects the equipment, patient positioning, and breathing maneuver (ex. deepinspiration breath hold) that will be used during treatment delivery.
After the imaging is acquired, the tumour and all surrounding organs at risk (OARs) are
contoured on the CT dataset that simulates the patient positioning and breathing maneuver
that will be used during treatment. An average CT dataset composed of all phases of the
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4D-CT to represent the full range of respiratory motion may be used, or the phase during
which treatment will be delivered if respiratory-gated or breath-hold delivery is going to
be used. These contours are used to define the exact size, shape, and location of the tumour
and organs for the treatment planning system. The accuracy of these contours is therefore
highly consequential for treatment accuracy, and 4D-CT motion artifacts are known to
affect these contours16–18. The causes of 4D-CT artifacts and their consequences are further
discussed in Section 1.7.3.

1.4.2

Treatment Planning

Once all contouring is complete, the 4D-CT and radiation dose prescription are passed to
a dosimetrist, who uses treatment planning software to plan exactly how the radiation dose
will be delivered from the linear accelerator. The treatment planning system uses the 4DCT to simulate how the radiation dose will be transmitted through and absorbed by the
body. The dosimetrist uses this information to ensure that the contour of the tumour
receives a sufficiently high dose, while the contours of all OARs receive a sufficiently low
dose19. For patients with advanced stage NSCLC, the standard dose to the planning target
volume (PTV) is 60 Gy, delivered in 30 daily fractions of 2 Gy each20.
The two most common delivery geometries are intensity modulated radiation therapy
(IMRT)21 and volumetrically modulated arc therapy (VMAT)22. IMRT is a 3-dimensional
treatment planning technique that entails delivering radiation from several static angles
around the patient, using beams which overlap over the tumour to create a region of high
dose. In IMRT, the beams used are non-uniform in order to optimize the dose distribution21.
This is accomplished using a multi-leaf collimator (MLC), which is made up of narrow
tungsten leaves which are individually positioned to shape the radiation field. A nonuniform distribution is achieved from a combination of static fields with different
geometry, or from moving the MLC to modulate the dose distribution while the beam is
delivered. In VMAT, the treatment gantry rotates constantly around the patient, while
delivering a continuous radiation beam. This beam is constantly modulated in intensity and
in shape, as are the dose rate and the rotation speed of the gantry, allowing for even greater
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optimization of the dose distribution22. The two geometries are shown below in Figure 13.

Figure 1-3 Typical dose distribution of external-beam radiation therapy.
An example of two possible dose distributions for NSCLC treatment. The IMRT plan (left)
shows the distribution of dose from several static beams delivered at set angles around the
patient. The VMAT plan (right) shows the distribution from a delivery which is varied
while the gantry rotates constantly around the patient. Adapted from Holt et al. with
permission23.

1.4.3

Radiation Treatment Delivery

The patient is treated lying in the same position as they were for the 4D-CT scan, usually
supine with their arms raised above their head. If the planned treatment does not encompass
the motion of the tumour due to respiration, then a respiratory motion management
strategy, discussed in Section 1.4.1, will be used15.
When the patient is set up in the treatment position, imaging may be used before treatment
to verify that the setup is accurate, and that the tumour is in the correct position. This is
accomplished using the kV x-ray imaging system that is present on most modern linear
accelerators. A pair of planar images are acquired and compared to the treatment planning
CT to ensure that the patient is aligned properly. More recently, daily cone-beam computed
tomography (CBCT) has been used for more accurate patient setup prior to treatment24,25.
Optical surface tracking is a new technology which enables position verification without
the use of ionizing radiation, and may be used before CBCT instead of planar kV imaging26.
In addition, imaging performed during treatment delivery can track respiratory motion to
enable respiratory motion management techniques, described in Section 1.5.124.
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During radiation therapy delivery, as the x-rays pass through the body, some will interact
with the tissue. The most common type of interaction at this x-ray energy and material type
is Compton Scattering27. Through this method, some of the energy from the x-ray is
deposited into the tissue and releases an energetic electron. The scattered x-ray may go on
to interact with other atoms in the body, and the electron will interact with nearby atoms,
depositing its energy. This process is continually repeated as treatment is delivered, and
this physical and chemical process will result in broken bonds within molecules, which
may lead to biological damage (damage to cells or to cell DNA). Using the distribution of
dose during delivery and the fraction of doses over a number of days, the dose is delivered
with the intention of inflicting the maximum possible damage on the tumour and the
minimum possible damage on the surrounding healthy tissues and OARs27.

1.5 Challenges in Radiation Therapy for NSCLC
Each disease site has challenges when planning and delivering radiation therapy, including
NSCLC. For this disease, two of the largest ongoing challenges are related to respiratory
motion and radiation-induced lung injury. This section of the thesis will explain the current
methods used to address these factors, and the unmet needs in this area.

1.5.1

Respiratory Motion Management

Treating NSCLC is inherently challenging due to respiratory motion, because radiation
therapy must be spatially accurate and internal organ and tumour motion during regular
breathing has a highly variable trajectory across patients28. Treatments are usually more
than one minute of beam-on delivery time, so patients cannot hold their breath for the entire
delivery. Therefore, the motion of the target and the surrounding organs at risk must be
well understood, and this motion must be controlled or accounted for during radiation
delivery. Respiratory motion management is applied when the motion of the target exceeds
5 mm15. The available technology and recommendations for use are outlined in the report
of AAPM Task Group 76 on the management of respiratory motion in radiation oncology15.
Motion management techniques include motion encompassment, breath-hold, tumour
immobilization, respiratory gating, and dynamic tumour tracking12,15. Motion
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encompassment is a method in which the gross tumour volume (GTV) is contoured on all
phases of the 4D-CT and the internal target volume (ITV), the union of all GTVs, is created.
In this way, the treatment volume is expanded to include some healthy tissue but ensures
that the tumour is always within the treatment field. Treatment is delivered while the patient
breathes freely. In breath-hold methods, the patient takes a deep breath and holds it for 1020 seconds at a time, which is verified using imaging or air-flow measurements. During
the breath hold, the tumour is stationary and treatment is delivered29,30. Tumour motion can
be minimized using abdominal compression, which forces shallow breathing by restricting
diaphragm motion. This technique is most often used for lower lobe tumours which are
closer to the diaphragm31,32. Respiratory gating is a free-breathing technique in which
imaging is used to track the patient’s breathing motion and enable treatment delivery only
in a certain window of the respiratory cycle (often during end-exhale)33,34. Motion may be
tracked using kV x-ray imaging, ultrasound, or optical tracking methods. This method is
comfortable for patients and spares healthy tissue surrounding the tumour but requires a
longer delivery time due to the pauses in delivery during every respiratory cycle, and relies
on the assumption that internal and external motion are highly correlated. It also requires
that the patient breathes in a consistent and reproducible manner, which is not always
possible for patients with poor pulmonary function. The last method, dynamic tumour
tracking, is a novel method which is not yet widely used. This is also a free-breathing
method, where the radiation beam is modified in real time during delivery to follow the
measured or assumed motion of the tumour. This method enables minimal dose to
surrounding tissues, and more efficient delivery than respiratory gating, but has
significantly greater technical requirements.

1.5.2

Radiation Induced Lung Injury

Some damage to healthy tissues and organs is inevitable when a patient receives radiation
therapy. The radiation delivered to the tumour will pass through healthy tissue before and
after reaching the tumour itself, causing damage along the path. When cellular damage is
detected in the body, an inflammatory response is triggered which may lead to symptomatic
radiation-induced lung injury. The severity of this radiation-induced lung injury (RILI) is
graded according to Table 1-1 below35–37.
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Table 1-1 Severity grading of radiation-induced lung injury
Grade RTOG
0
No changes

CTCAE v. 5.0
No changes
Asymptomatic, only radiological,
or tomographic findings

1

Asymptomatic or mild symptoms

2

Moderate symptoms of pneumonitis
(severe cough) and radiographic changes
(radiographic patches)

Symptomatic, does not interfere
with daily activities

3

Severe symptoms of pneumonitis, dense
radiographic changes

Symptomatic, interferes with
daily activities, requires
supplemental O2

4
5

Symptoms of severe respiratory failure
Threatens life, requires
requiring assisted ventilation or continuous
mechanical ventilation support
O2
Death-related late effects of radiotherapy
Death related severe pneumonitis

The lungs are highly sensitive to radiation, and care is taken to minimize the dose to the
healthy lung when treating NSCLC. In spite of this, approximately 30% of patients who
undergo treatment for NSCLC will experience RILI3. This injury is typically broken down
into an early (inflammatory) toxicity and a late (fibrotic) toxicity37. The injury process is
illustrated in Figure 1-4 below. In the early stage, increased inflammation begins within
days. Approximately 3-12 weeks after radiation exposure, epithelial and endothelial cell
degradation leads to alveolar collapse37. This inflammatory cascade will reach the fibrotic
phase 6 months or more after radiation therapy. In this late stage myofibroblasts and
collagen deposits are present, thickening the alveolar wall and reducing lung function37.
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Figure 1-4 Radiation induced lung injury process.
This figure illustrates a simplified pathway by which radiation exposure leads to radiation
pneumonitis and potentially permanent fibrosis. Ionizing radiation causes direct DNA
damage, and the production of free radicals. These lead to oxidative stress and vascular
damage, triggering a local inflammatory response. At this stage, radiation pneumonitis may
occur. This process may cause damage to vascular and alveolar cells, and the late
inflammatory stage leads to the development of fibrotic tissue, which may cause permanent
fibrosis. Adapted from Hanania et al38. with permission.
The lungs are a parallel organ, which means the function of one region of the organ is
generally not dependent on the function of another region. For this reason, a high dose to
a small volume of the lung may not result in clinically significant damage, as the remainder
of the organ is functioning well enough to compensate for the small damaged region.
However, dose to a large volume of the lungs may significantly reduce their overall
function39.
The volume of lung tissue receiving over 20Gy is a known predictor of severe
pneumonitis3,40. Therefore, in clinical practice, the volume of healthy lung tissue that is
irradiated is minimized. However, in current clinical practice all lung tissue is weighted
equally and the functional heterogeneity common in patients with NSCLC is not
considered. One method which has been explored to reduce the clinical impact of radiation
pneumonitis is to include functional lung imaging in the treatment planning process41,42.
The assumption underlying this technique is that many patients who develop NSCLC have
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respiratory co-morbidities such as COPD from a history of smoking or environmental
exposures, leading to heterogeneous function throughout the lungs. If the highly
functioning regions of the patient’s lungs are preferentially spared, it may reduce the risk
of symptomatic pneumonitis. Functional lung imaging, including ventilation and perfusion
imaging discussed in Sections 1.9 and 1.10 respectively, may be used to spatially map
function in the lungs, to indicate regions to be prioritized for dose reduction in treatment
planning. While there is not yet a consensus on the methods that are best suited to mapping
ventilation and defining avoidance regions, early clinical trial evidence supports the
hypothesis that this approach can significantly reduce toxicity43.
This thesis focuses on the potential applications of volumetric computed tomography
(explained in Section 1.6 below) in 4D-CT imaging for treatment planning, and for imaging
lung function. These applications may be impactful in both research and clinical practice.
First computed tomography and 4-dimensional computed tomography will be discussed,
followed by the methods and applications of ventilation and perfusion imaging.

1.6 Computed Tomography
Computed tomography imaging was developed 50 years ago to create 3-dimensional
images of a patient’s body based on x-ray attenuation, which reflects tissue density44. The
techniques used to acquire and reconstruct these images have evolved since then but have
been largely consistent in the past few decades. This section will review the current
methods used to create CT images, including the strengths and weaknesses of current
methods.
The technological approach used to acquire CT images has evolved dramatically in the 50
years since its first use. Figure 1-5 below shows how CT scanner configuration has
evolved. In first generation scanners, the x-ray tube and a single detector translated linearly
to create a projection image from parallel beams. The system rotated around the patient,
collecting a series of these parallel beam projections. Second generation scanners used the
same translate-rotate geometry, but a small array of detectors was used so the x-rays were
emitted in a fan beam. These were quickly replaced by third generation detectors, which
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used a rotating fan beam source, and a larger rotating curved array of detectors positioned
opposite to the source.
Finally, multi-slice detector arrays were introduced so that multiple axial slices could be
imaged in a single rotation. The x-rays are now projected in a narrow cone-beam geometry,
with the fan angle and cone angle used to define the size of the beam, which determine the
field-of-view (FOV) and axial field-of-view (aFOV) respectively45. The cone angle used
in these scanners has been gradually widening, as methods to reconstruct images without
cone-beam artifacts (discussed in Section 1.6.4) improve. From approximately 1998 to
2008, the number of detector rows increased by a factor of four every two to three years46.
The widest arrays currently used have 256-320 detector rows, providing an aFOV of 160
mm. The adoption of these scanners in radiation oncology has been slow, in part due to the
increased cost of these scanners as compared to 32 or 64 detector row models. However,
they provide many advantages in radiation therapy, as will be discussed in detail in Section
1.8.

Figure 1-5 The evolution of CT scanner configurations.
A. The parallel beam projection method from 1st generation scanners. B. The rotate-rotate
fan-beam projection geometry used in 3rd generation scanners. C. The narrow cone-beam
and multi-detector array geometry used in multidetector CT scanners, and advanced in
volumetric (or area detector) CT scanners. Adapted from Bushberg et al45.

1.6.1

CT Image Acquisition and Reconstruction

To acquire a CT image, x-rays are emitted in a fan geometry from one side of the scanner
bore and pass through the patient who is lying on the couch inside the bore. Some of the xrays are attenuated as they pass through the patient’s body, with the degree of attenuation
depending on the thickness and electron density of the tissue in the beam path. The
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remaining x-rays reach a set of detectors located on the side of the bore opposite the x-ray
source. The entire system rotates on a gantry around the bore, collecting projection images
from multiple angles around the patient’s body. This geometry is shown in Figure 1-6. The
fan beam only passes through a narrow slice of the patient’s body, so the couch moves the
patient incrementally through the imaging bore so the process may be repeated along the
length of the region being imaged45.

Figure 1-6 CT acquisition.
X-rays pass from the source in a fan beam or narrow cone beam geometry through the
patient. The x-rays are attenuated proportionally to the electron density and thickness of
the tissue they are passing through, and the remaining x-rays are detected by the array of
detectors on the other side of the scanner. The entire scanner rotates around the patient’s
body, collecting projection images.
The many projection images must now be reconstructed to create a cross-sectional image
through the patient’s body. There are two categories of reconstruction; filtered backprojection and iterative reconstruction. Filtered back-projection was long the dominant
method used, but iterative methods have been increasing in use as computing power has
advanced. In this thesis, computed tomography images were all reconstructed using filtered
back-projection, but images generated by iterative reconstruction may also be used in the
future.
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The final 3-dimensional CT image of a patient is given in Hounsfield Units (HU)44, which
is defined in Equation 1-1 below.
Equation 1-1
𝐻𝑜𝑢𝑛𝑠𝑓𝑖𝑒𝑙𝑑 𝑈𝑛𝑖𝑡 = /

𝜇!"##$% − 𝜇&'!%(
2 × 1000 [𝐻𝑈]
𝜇&'!%(

In the equation above, 𝜇!"##$% and 𝜇&'!%( are the linear attenuation coefficients of tissue
and water, respectively. CT number, measured in Hounsfield Units (HU), is unitless, but
can be converted to a measure of electron density using a scanner-specific calibration
curve. CT imaging is used in planning of radiation therapy because this 3-D map of electron
density is used to estimate the deposition of dose from an electron or x-ray beam delivered
for therapy. CT images are used to generate treatment plans according to the desired
distribution of dose as described in Section 1.4.2.

1.6.2

Imaging Artifacts

An imaging artifact is any effect which results in inaccuracy in some or all of an image.
These may be caused by patient motion, hardware or software limitations, or inaccurate
assumptions underlying image generation. These artifacts may be visually obvious and
may or may not be easily quantifiable. In this section, the many potential artifacts in CT
imaging for radiation oncology applications will be discussed, as well as current methods
and opportunities to reduce or eliminate them for optimal imaging accuracy.
Common artifacts in CT acquired for treatment planning are beam hardening and streak
artifacts, which both occur when imaging high density materials such as bone or medical
implants. These artifacts are illustrated in Figure 1-7 below. Beam hardening artifacts occur
when the assumption of an effective linear attenuation coefficient is broken. The x-ray
beam used in CT contains photons in a range of energies, and an effective linear attenuation
coefficient is used in image reconstruction. However, if the beam passes through thick bone
or other high-density material, low energy x-rays are preferentially attenuated, and the
beam is harder (has a higher average energy). The ray passes through the tissue behind this
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dense material with lower attenuation than expected, and this tissue is therefore assigned a
lower attenuation value. It appears as a dark region or streak in the final image45. Streak
artifacts occur when a material, such as a dental filling, has such high density that it exceeds
the range of the detectors. Therefore, in each projection it appears that the object is larger
than it actually is, because so many x-rays were attenuated. When the final image is
reconstructed, the object casts bright streaks around it, obscuring the surrounding
structures45.

Figure 1-7 Example images of CT artifacts.
Example images illustrating (A) streaking artifact from cone beam image (B) a severe
streaking and beam hardening artifacts caused by dual hip prostheses. Adapted from Tang
et al47. and Axente et al48.
When a narrow cone beam or full cone beam are used, cone beam artifacts may occur.
These are a result of under-sampling in the direction of the cone angle (usually denoted as
the z-direction), particularly for detectors at the edge of the cone49. These artifacts appear
as streaking or stair-step artifacts if there is a high-contrast edge along that direction45,50.
An example image is shown in Figure 1-7 above. Hardware solutions such as anti-scatter
grids and advanced reconstruction techniques have enabled companies to produce
volumetric CT scanners with a wide enough cone angle to enable 160 mm axial field-ofview with minimal cone artifacts in the resulting images50. These scanners are discussed in
detail in Section 1.8.
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1.7 4-Dimensional Computed Tomography
4-dimensional computed tomography (4D-CT) is a technique that was developed in
response to a need to better capture and account for the respiratory motion of lung tumours
during treatment planning and delivery. The technique used to generate 4D-CT was
developed in the early 2000s, with the first paper using an external signal of respiratory
motion published in 200251. Several other papers were published shortly after this, taking
advantage of multi-slice (4-slice or 8-slice) CT scanners using cine mode acquisition52, and
16-slice scanner with helical acquisition53.
These early studies lay the groundwork for the currently used 4D-CT protocol, which is
often acquired with a helical acquisition on a multi-slice CT scanner with an external
motion tracking system, as described below. 4D-CT is currently the standard of care for
many patients receiving radiation therapy for sites in the liver and lungs, which are heavily
influenced by respiratory motion. In these sites, tissue has been shown to move up to 20mm
during free breathing54,55. To plan and deliver radiation accurately to the target and
minimize dose to the surrounding tissues, this motion must be understood and accounted
for. 4D-CT enables several different methods to account for motion: first, target contours
can be drawn to encompass the full range of motion of the target such that surrounding
healthy tissue receives an increased radiation dose, but the target is not under-dosed.
Alternatively, a plan may be generated on a single phase of the respiratory cycle, usually
end-exhale as it is the longest lasting and most stable of the phases. This requires
measurement of the respiratory motion during delivery and gating the treatment beam on
only when the tumour is thought to be in the correct location.

1.7.1

4D-CT Acquisition

There are two main categories of 4D-CT acquisition, axial and helical. In an axial
acquisition, the patient breathes freely lying supine on the CT couch in the treatment
position. A series of images are acquired in a static position, so the entire breathing cycle
has been imaged. Image acquisition is then briefly paused while the couch shifts, to image
the next volume. This process is repeated until the entire volume of interest has been
scanned. In a helical acquisition, images are continuously acquired as the patient breathes
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freely. During the acquisition, the couch moves slowly forward into the bore as the x-ray
source and detector rotate, creating the helical pattern of data acquisition. The pitch of the
couch (the speed at which the couch moves forward) is calculated by the width of the aFOV
and the patient’s respiratory rate to ensure that each anatomical slice is imaged for an entire
respiratory cycle before passing out of the field of view of the scanner53. This process is
shown in Figure 1-8 below. During the acquisition, the patient’s respiratory motion is
monitored using an external motion tracker such as an infrared camera and reflecting block,
respiratory bellows, or a whole-body infrared camera system. This external motion is used
to identify what phase or amplitude of the breathing cycle the patient is in at that moment
in time.

Figure 1-8 4D-CT acquisition
The schematic above illustrates how helical 4D-CT images are acquired. The patient lies
supine on the CT couch and breathes freely while the couch slowly moves through the
scanner bore. The x-ray source and detector are constantly rotating around the patient, so
image data is collected in a helical pattern and each slice location is imaged through an
entire respiratory cycle.
This method is used under a set of assumptions which may not always be satisfied. The
first of these is that patient breathing motion is stable and at a consistent amplitude and
frequency throughout the duration of the scan. The second is that the external motion of
the patient’s chest or stomach accurately reflects the internal motion of the diaphragm and
lungs in both phase and amplitude. Studies of the correlation of internal and external
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respiratory motion suggest that they are usually highly correlated, but there is sometimes a
phase delay between internal and external motion56–59. Coaching the patient as they breathe
can improve this correlation, but takes longer to implement and therefore may reduce
patient throughput60.

1.7.2

4D-CT Reconstruction

After the scan is complete, there is a large set of CT projections from the helical acquisition,
which are all tagged with an exact location along the z-axis and the precise time of
acquisition. This time is compared to the external motion tracking data to determine what
phase of the respiratory cycle each projection belongs to. Then, the projections are all
sorted such that for every phase in the respiratory cycle, there are sufficient projections at
every slice location to create a full 3D volume. If there are insufficient projections for a
particular slice and phase, data from the closest possible phase may be used to fill in the
missing data and complete the image as accurately as possible.
There are two main categories of 4D-CT reconstruction: phase-based and amplitude-based.
In phase-based reconstruction, all end-inhale points of the respiratory curve are identified,
and the data points in between each end-inhale point are equally divided into 8-10
respiratory phases. This method relies on the assumption that (relative to the total length
of the breathing cycle) the time taken from inhale to exhale and back to inhale is the same
every time. In amplitude-based reconstruction, specific positions (amplitudes) of the
external motion are identified to represent the end-inhale and end-exhale positions. Then
the distance between the two positions is divided into 5 segments, for a total of 10 positions
from end-inhale to end-exhale. This process is depicted in Figure 1-9 below.
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Figure 1-9 4D-CT Reconstruction.
The above schematic illustrates how 4D-CT images are reconstructed. The blue breathing
trace at the top of the image represents the respiratory data collected from an external
monitor. The images or sinogram data have a location and time, which correspond to a
location and phase of the respiratory cycle. Using these two parameters, the images or
sinogram data are sorted into 8-10 “bins” representing each phase of the respiratory cycle
so an entire 3D image may be reconstructed at each phase.

1.7.3

4D-CT Motion Artifacts: Causes and Types

As detailed above, there are two key assumptions made when acquiring and reconstructing
4D-CT images. In particular, the assumption that the patient’s breathing will remain stable
and consistent in amplitude and frequency throughout the scan is often not held true. Many
patients undergoing 4D-CT simulation are nervous and are not able to relax into their
resting breathing pattern until partway through the one- to two-minute scan. In addition,
many of these patients experience breathing difficulties due to their lung cancer or comorbid conditions such as COPD, resulting in an inconsistent respiratory motion trace
through the scan.
There are three common patterns of irregular respiration data: incomplete sampling,
baseline drift, and irregular amplitude. The first refers to the case where the frequency of
the patient’s breathing decreases as they relax after the start of the scan. The patient’s
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respiratory rate is used to determine acquisition parameters such as the couch pitch in a
helical scan. If breathing rate decreases, then a slice will not be imaged for the entire
respiratory cycle before it moves out of the FOV of the scanner. With this incomplete data,
projections from the nearest possible slice and respiratory phase will have to be used to
complete the image, resulting in a loss of accuracy. The other two types of irregular motion
refer to mostly to changes in amplitude. In a baseline drift condition, the amplitude and
frequency of a patient’s breathing is largely unchanged, but the entire respiratory curve
shifts due to patient movement or a change from shallow to deeper breathing with
relaxation. In this case, it can be difficult or impossible to correctly match images taken at
the beginning of the scan to images from the same phase later in the scan. One slice in an
image may not really be from the same respiratory condition as another slice in the image,
so the depicted anatomy is not entirely correct. Lastly, in the irregular amplitude condition
the patient breathes erratically, taking some deep and some shallow breaths. This may
affect both amplitude and frequency of breaths, and as above, makes it difficult or
impossible for the reconstruction algorithm to accurately sort all images correctly by phase
or amplitude. In previous research, phase-based binning often leads to more motion
artifacts in the final 4D-CT images than amplitude-based binning, but both techniques are
used clinically.
The artifacts which result from these irregular breathing patterns vary widely in appearance
and severity. However, they can be classified into four artifact types which are easily
visually identified61. Example images of these artifacts are shown in Figure 1-10.
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Figure 1-10 Types of 4D-CT motion artifacts.
Four types of motion artifacts are shown in examples from a Quasar Respiratory Motion
Phantom and from the treatment planning 4D-CTs of three patients with NSCLC. Each
artifact is highlighted with a yellow arrow. Adapted from Yamamoto et al61.
The impacts of 4D-CT motion artifacts in radiation therapy can be significant. Studies have
shown that these artifacts can lead to inaccurate GTV contours16,62, which may result in
under-dosing the target or over-dosing surrounding healthy tissue. In addition, these
artifacts can lead to inaccurate contouring of surrounding organs at risk, which may again
result in the delivered dose not matching the intention of the treatment plan. This has been
proven to affect patient outcomes, with a 2020 study showing that in patients with liver
cancer, the presence of 4D-CT motion artifacts was associated with reduced local control
of the disease63.
Efforts have been made to reduce motion artifacts, addressing the problem from different
aspects of the imaging process. One approach has been to improve the image sorting and
reconstruction process64,65. This approach generally requires an increased imaging dose to
acquire additional data to compensate for irregular breathing motion. Other methods
include coaching, where digital tools are used to assist patients in breathing at a consistent
pace and amplitude for the duration of the scan66. These methods generally require an
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increased appointment time as the patients must be taught how to use the coaching device
and get comfortable using it.

1.8 Volumetric Computed Tomography
Until recently, CT scanners collected data in a fan-beam geometry to prevent unacceptable
scattering artifacts produced from using a cone-beam geometry (these are explained in
Section 1.6.2). When a cone-shaped beam is used there is increased scatter, and increased
variation in beam intensity and energy received at the detector. These factors must all be
accounted for in vCT scanners to minimize cone-beam artifacts in the reconstructed
images. In early iterations of this technology, these cone-beam effects were shown to
degrade image quality as compared to a conventional narrow-aFOV CT scanner67.
Throughout the following decade, methods used to reduce these artifacts generally fell into
two categories; hardware designed to reject scattered photons at the detector, and software
designed to compensate for the presence of remaining scattered photons during image
reconstruction. Using one or both techniques, CT manufacturers are now able to use “wide
fan” geometries, which approach a cone beam, and reconstruct images with acceptable
image quality for radiology.

1.8.1

Volumetric CT Scanners

Currently, these scanners are capable of imaging a volume with an axial field-of-view
(aFOV) of 16.0 cm, and an in-plane field-of-view (FOV) of 50.0 cm. These scanners are
called volumetric scanners (because a larger volume is imaged in a single rotation) or area
detector scanners (because to capture this wide fan beam, the detectors used are much
wider, i.e. 256-312 detectors as compared to 32-64 detectors). This difference in scanner
geometry is shown in Figure 1-9 below. These scanners can capture large volumes very
quickly, which is advantageous when one is imaging a moving part of the body or wants
to collect a dynamic image series across a large volume with high temporal resolution.
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Figure 1-11 Volumetric CT geometry.
A typical clinical CT scanner (left) has a narrow cone angle, giving a narrow aFOV (24
mm in this example). In a volumetric CT scanner (right), a much wider cone angle is used,
giving an aFOV of up to 160 mm.
In addition, this approach may have dose-reduction benefits. When comparing the imaging
dose of a different 256-slice CT scanner (aFOV = 128mm) to a conventional 16-slice
scanner, a 2014 study found that the dose from the 256-slice scanner was lower68. This was
because the margin on the axial edges of the beam contributed less dose to the patient when
a wide (128 mm) beam was used compared to when a narrow (16 mm) beam was used.

1.8.2

Volumetric 4D-CT

As discussed in Section 1.7, 4D-CT is an important part of the treatment planning process
for NSCLC and other thoracic cancers. Capturing the effects of respiratory motion and
appropriately compensating for this motion is essential to accurate radiation delivery. 4DCT imaging must encompass a large volume (usually greater than 200 mm in length), and
most clinical CT scanners have a narrow aFOV (often less than 40 mm), so they are prone
to motion artifacts due to inconsistent patient breathing. Volumetric CT scanners can
acquire 4D-CT across a 160 mm aFOV (or 140 mm aFOV with full lateral FOV) in a single
couch position, because that entire volume is captured in a single rotation. Therefore, 4DCT of that volume can be acquired within a single respiratory cycle with no visible motion
artifacts. In addition, new CT scanners have faster rotation times than previous generations,
reducing blur within images due to respiratory and cardiac motion.
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To capture a longer field, a second or third couch position will be necessary, and a small
overlapping region between each couch position may greatly reduce motion artifacts with
minimal additional radiation dose. Image acquisition may also be performed in cine mode,
which means that the x-ray beam is on and projection data is constantly being acquired for
the duration of the scan. Cine mode acquisition allows reconstruction of images with very
high temporal resolution (down to 0.1 s between images). This can also be used to
accurately match images acquired from different couch positions to the same respiratory
phase, resulting in minimal motion artifacts. The reduction of motion artifacts in v4D-CT
and the quantitative improvements in contouring will be explored in Chapter 3 of this
thesis.

1.9 Ventilation Imaging
This section will review the imaging methods used to estimate the regional distribution of
ventilation, which describes the flow of air into and out of the lungs. Imaging methods
directly or indirectly measure the amount of air, or a tracer, that was delivered to a voxel
within the lungs, which is assumed to be directly related to the air flow in that region.

1.9.1

Contrast-Enhanced CT Ventilation Imaging

Ventilation can be directly measured by CT using the inhalation of
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Xe, which is radio

opaque. Researchers began studying this over 40 years ago69,70, but the amount of work
done in the area has greatly increased since 200071, and has been done in both animal and
human studies. Generally, lower concentrations of Xe gas are used for human studies to
minimize the sedative effects of Xe. Often, multiple breaths of Xenon are used so the gas
has ample opportunity to fully wash into the lungs. Images may be acquired during the
wash-in process to map wash-in and wash-out constants71,72, or a single image each from
baseline and estimated peak Xe concentration may be used73. In the latter case, both images
are acquired at the same place in the breathing cycle to ensure that the change in density is
from Xenon alone. One recent study demonstrated the feasibility of imaging ventilation
with a single breath of high-concentration (70%) Xenon73. Image registration and
subtraction can then be used to map the change in electron density, which is linearly related
to the amount of Xenon in each voxel71 and assumed to be directly related to ventilation
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within that region. Xe is able to diffuse into the bloodstream, so measures of gas exchange
and perfusion are also possible using inhaled Xe74.

1.9.2

Non-Contrast Enhanced CT Ventilation Imaging

This method has been used on breath-hold CT images acquired at end-inspiration and expiration, and on end-inspiration and -expiration phases of a 4D-CT scan. Deformable
image registration is used to register the inspiration image to the expiration image, and the
density change at each voxel is assumed to be the result of a change in air content in the
voxel. The first published method to derive a ventilation map from 4D-CT uses the
following formula in which HUin and HUout are the CT number of the voxel in the inhale
and exhale images, respectively, to calculate specific ventilation, SV75:
𝑆𝑉 = 1000 ×

𝐻𝑈") − 𝐻𝑈%*
𝐻𝑈%* (1000 + 𝐻𝑈") )

This method estimates specific ventilation, which is ventilation per unit lung volume.
Several different formulas have since been developed to convert the two images into the
most accurate ventilation map possible. When compared to direct measures of ventilation
such as PET and MRI methods, the performance of this class of methods has varied
widely76,77.
Shortly after the publication of the first density-based method for non-contrast enhanced
CT ventilation imaging, another method was published which does not require a density
calculation but relies on the deformation vector field generated by registration between
inhale and exhale images. The following formula is applied to the deformation vector field,
u(x,y,z), to calculate the Jacobian determinant of the field, J78:
𝜕𝑢* (𝑥, 𝑦, 𝑧)
𝜕𝑥
B
𝜕𝑢+ (𝑥, 𝑦, 𝑧)
𝐽(𝑥, 𝑦, 𝑧) = 1 +
𝜕𝑥
B𝜕𝑢 (𝑥, 𝑦, 𝑧)
,
𝜕𝑥
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𝜕𝑢* (𝑥, 𝑦, 𝑧)
𝜕𝑦
𝜕𝑢+ (𝑥, 𝑦, 𝑧)
𝜕𝑦
𝜕𝑢, (𝑥, 𝑦, 𝑧)
𝜕𝑦

𝜕𝑢* (𝑥, 𝑦, 𝑧)
𝜕𝑧
B
𝜕𝑢+ (𝑥, 𝑦, 𝑧)
𝜕𝑧
𝜕𝑢, (𝑥, 𝑦, 𝑧) B
𝜕𝑧

Many variations of this original approach have been published to attempt to improve the
stability and accuracy of the method79–82. To date, registration-based CT ventilation
imaging methods show low to moderate correlation with gold-standard methods and
contrast-enhanced methods described above76.
The reasons for the variable correlation between non-contrast enhanced CT methods with
gold-standard methods are debated and may be broken down into three main categories.
The first possible cause is the images used for ventilation calculation. 4D-CT motion
artifacts have been shown to cause artifacts in ventilation imaging, so every effort to reduce
motion artifacts can be expected to support more accurate ventilation calculations83.
Breath-hold imaging is a possible way to address this problem, but this would require
additional imaging dose to the patient and does not represent the way the patient will be
breathing during radiation therapy in most cases. The second variable is the choice of image
registration method. Both density-based and registration-based ventilation calculations are
highly dependent on the image registration used84, so consistently accurate registration is
required for consistently accurate ventilation mapping. The final variable is the method
used to calculate ventilation maps, and there is still much research activity ongoing to
optimize these methods. However, no method will be reliable without high quality images
and registration.

1.9.3

Other Methods of Ventilation Imaging

Nuclear imaging was the first method used to image lung ventilation, initially using
radioactive 81mKr nearly 50 years ago85, followed by 133Xe86. Today, the standard method
uses aerosolized solid particles labelled with

99m

Tc, called Technegas87. Inhaled particles

are deposited by collision with the airway walls and by diffusion in the alveoli88. The
deposited particles are then imaged by SPECT, generating a relative map of ventilation.
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Ga can also be used in a Technegas generator to create an aerosol agent suitable for PET

imaging, called “Galligas”89. While PET imaging is more expensive and less widely
available, it has high sensitivity and spatial resolution90.
MRI has been used to measure ventilation directly and indirectly. Hyperpolarized noble
gas MRI is a direct measure of ventilation in which a noble gas isotope (most commonly
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Xe) goes through a “hyperpolarization” process. The patient inhales a volume of this

hyperpolarized gas and holds their breath while the gas itself is imaged by the MR
scanner91,92. In the resulting image, the strength of the signal in each voxel is assumed to
be directly related to the volume of noble gas contained in that voxel, and therefore a
measure of the flow of air into that region of the lung in a single breath. The patient’s
anatomy is also imaged in breath-hold for anatomical reference. Non-contrast methods
have also been developed to estimate ventilation using MRI sequences used under breath
hold93,94 or while free breathing95,96.
The rapid growth of machine learning and deep learning in medical imaging has also led
to recent investigations of deep learning techniques to derive ventilation images directly
from 4D-CT or breath-hold CT images. Several studies have been published in the past 5
years demonstrating the many ways this approach can be used97–100. The published results
are highly variable by method, and many have not yet undergone validation with an
external dataset. However, these methods show moderate correlation with accepted
methods, and are a promising avenue for future research.

1.10 Lung Perfusion Imaging
This section will review the methods used to image perfusion, or blood flow, in the lungs.
Most images use an injected contrast agent which will change the signal intensity in each
voxel of the resulting image. As with ventilation imaging, perfusion information is useful
in assessing lung health and function for a variety of applications and may be useful for
making treatment decisions for patients with NSCLC, such as suitability for surgery or for
functional avoidance in radiation therapy.

1.10.1

Nuclear Perfusion Imaging

Ventilation and perfusion imaging were among the early uses for nuclear imaging, which
began with 2-dimensional scintigraphy. Today, both SPECT88,101 and PET102 are used to
generate 3-dimensional images of perfusion. This technique was first used in SPECT, when
macroaggregated human albumen (MAA) is labelled with a radioactive tracer, usually
99m

Tc, which emits gamma rays for SPECT imaging. It was later shown that by using the
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same method, the MAA can also be labelled using 68Ga, which emits positrons for PET
imaging103. When the labelled MAA is injected into a vein, it travels with the blood through
the right side of the heart and into the lungs through the pulmonary artery. The MAA
particles are too large to pass through the capillaries in the lungs and become lodged there.
The number of lodged particles in a region of tissue, and therefore the signal measured
from that tissue, is proportionate to the blood flow through that area.

1.10.2

CT Perfusion Imaging

Dynamic contrast-enhanced CT perfusion takes advantage of the high temporal (0.5 s or
less per image) and spatial (0.625 mm in-plane) resolution of modern CT scanners. It is a
well-established technique for measuring blood flow and related properties such as mean
transit time104. It has been validated for use in the lungs under breath-hold conditions, and
is used widely in the brain and other organs104.
The imaging procedure involves the venous injection of a bolus of iodine-based contrast,
which reaches the organ of interest. The contrast agent strongly absorbs imaging x-rays
(usually 100-120 kVp)105, so it causes CT signal enhancement as a linear function of the
concentration105. After injection, it is assumed to be uniformly mixed with the blood. High
temporal-resolution imaging is acquired as the contrast washes into the organ, passes
through the arteries into the capillaries, and travels out through the veins. The contrast
agent can permeate the blood vessel walls, so some contrast diffuses out of the vessels and
into the surrounding interstitial space104.
Dynamic CT perfusion is an analysis of the change in CT number within a voxel over time.
Therefore, image registration may be required to ensure that a single voxel captures the
same tissue region throughout the entire image series. The registered images are then
analyzed using a deconvolution-based method, which requires variables defined here. The
blood flow is the rate of flow through a blood vessel (F, units: mL/min/100g), the
concentration of contrast agent in the artery is Ca(t), and the signal from a single voxel over
time is called the time-density curve (Q(t))104.
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If we consider a special case where the arterial concentration of contrast approaches a delta
function (an infinitely narrow volume of contrast in which unit mass is deposited
instantaneously in the region to be measured) then the time-density curve would take a
particular form called the impulse residue function (IRF, R(t)). Plots to demonstrate these
functions are given in Figure 1-12. To approach a more realistic scenario, one may imagine
an arterial concentration composed of a series of delta functions of different heights, and
the limit as this function becomes continuous. The tissue time-density curve (TDC) will
then be made up of a series of IRFs, and in the continuous limit, also becomes a continuous
function. The TDC can therefore be defined by Equation 1-2 below where ⨂ is the
convolution operator104:
Equation 1-2
𝑄(𝑡) = 𝐹 ∙ 𝐶' (𝑡)⨂𝑅(𝑡)
In Equation 1-2 above, Q(t) is the time-density curve, F is the rate of flow, Ca(t) is the
concentration of contrast agent in the artery, and R(t) is the impulse residue function.
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Figure 1-12 Convolution of an arterial contrast concentration curve and an impulse residue
function.
This figure illustrates the convolution process by which the time-density curve measured
in tissue can be derived from the convolution of an arterial contrast concentration curve
and an impulse residue function. Adapted from Miles and Cuenod104.
If the TDC and Ca(t) are known from the image data, then R(t) is calculated for each voxel
by deconvolving Ca(t) from the TDC, and blood flow (F) is the height of R(t). Medical
software is available for this analysis, and for this thesis a modified trial version of the
software was used (CT Perfusion, GE Healthcare, Milwaukee).
For lung perfusion imaging, a bolus of iodine-based contrast is injected into a vein, which
moves with the blood flow into the heart and through the right atrium and ventricle, into
the lungs via the pulmonary artery. In this case, the pulmonary artery is used to define the
arterial input function. If the images are acquired during free-breathing, then deformable
image registration is required to register the entire image series before voxel-wise analysis.
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1.10.3

Ventilation-Perfusion Imaging

As described in Section 1.2, both ventilation and perfusion must occur in the functional
units of the lung, the alveoli, for gas exchange, the function of the lungs, to occur. If either
ventilation or perfusion is reduced, the function of that lung region is also reduced. Changes
such as these appear clearly in a ventilation-perfusion ratio (V/Q) map. For example, in the
case of a pulmonary embolism, perfusion to a region of the lung is suddenly reduced due
to a blood clot, but ventilation is largely unchanged. Therefore, the V/Q ratio will be higher
in this region of the lung than the surrounding areas.
V/Q imaging is a well-established technique in nuclear medicine, used to diagnose
pulmonary embolism and other disorders88,90. First, ventilation imaging is performed as
described in Section 1.9.3. Then, there must be a waiting period to ensure that the signal
from the ventilation imaging tracer has sufficiently decayed and will not contaminate the
perfusion image. The perfusion imaging is performed with a higher radiation dose than
ventilation, so it is performed second to ensure that one signal does not contaminate the
other. Perfusion imaging with PET or SPCT is performed as described in Section 1.10.2.
The voxel-by-voxel ratio of the two images is calculated to generate a V/Q map, which is
then typically analyzed qualitatively by a radiologist for signs of pathology.
As introduced in Section 1.5.2, functional lung imaging has been proposed as a method to
reduce the chance of RILI by prioritizing the sparing of highly functional lung tissue. There
have been many studies showing that avoidance volumes can be generated from
ventilation41,42,106,107 or perfusion imaging108–110, and a small number of studies
incorporating both ventilation and perfusion from nuclear imaging111,112. While ventilationalone or perfusion-alone methods show promise, each provides an incomplete picture of
lung function. In patients with NSCLC, PET-CT based ventilation, perfusion, and V/Q
imaging were each shown to contribute unique information about the patient’s lung
function, as correlation between ventilation and perfusion maps varied widely113. This
suggests that ventilation, perfusion, and V/Q ratio should all be studied to determine which
metric, or combination of metrics, performs best in reducing risk of RILI in patients. One
animal study has reported CT perfusion as a stronger predictor of CT-measured density
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change than CT-based Jacobian ventilation, but the clinical consequences of this finding
require further study114. So far, studies to explore all these metrics rely largely on nuclear
imaging methods. However, PET imaging is costly, and clinical translation of PET V/Q
imaging for all patients is unlikely. If V/Q imaging could be performed using CT in the
same session as CT simulation for treatment planning, it may be more easily and widely
applied. There is therefore a need for an accurate method for CT-based V/Q imaging which
can be easily integrated into existing clinical routines.
V/Q imaging using CT has been shown to be feasible in patients with suspected pulmonary
embolism115 but is not part of any clinical standard of care. This is due, in part, to the fact
that dynamic CT perfusion imaging has not been possible over the entire lung volume at
high temporal frequency. In this thesis, we took advantage of the wide axial field-of-view
of a volumetric CT scanner to generate both ventilation and perfusion imaging in a single
dynamic contrast-enhanced CT scan. This enabled CT-based ventilation, perfusion, and
V/Q mapping in NSCLC patients for the first time. This method is introduced in Chapter
4 of the thesis and may have wide applications in research and clinical practice.

1.11 Thesis Hypotheses and Objectives
The goals of this thesis are to demonstrate the utility of volumetric CT for clinical and
research applications in radiation oncology, and to develop a simple functional lung
imaging pipeline to generate ventilation, perfusion, and ventilation-perfusion ratio imaging
using a volumetric CT scanner. In this thesis I developed and demonstrated how new
imaging protocols using volumetric CT advance both anatomical and functional lung
imaging in ways that can be implemented to impact clinical care and provide new
opportunities for clinical research into lung function in patients with thoracic cancers. The
specific research objectives of this thesis are:
1. To test the utility of volumetric CT imaging for simulation and radiation treatment
planning using a Catphan phantom.
2. To study the reduction in respiratory motion artifacts when 4D-CT imaging is
performed on a volumetric CT scanner, and quantitatively evaluate the impact of
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this artifact reduction on contours of images of a motion phantom and patients with
NSCLC.
3. To develop, validate, and demonstrate the feasibility of using a pipeline for
generating ventilation, perfusion, and ventilation-perfusion ratio (V/Q) images in a
single imaging session using a volumetric CT scanner.

1.12 Thesis Outline
In Chapter 2, I demonstrated the utility of volumetric CT imaging for simulation and
radiation treatment planning using a Catphan phantom. Volumetric CT scanners have a
much wider cone angle than CT simulators used in the past, so it was important to validate
that no artifacts were present that would decrease the accuracy of CT number in treatment
planning images. This work was previously published in the Journal of Applied Clinical
Medical Physics: Young HM, Park CK, Chau O-W, Lee T-Y, Gaede S. Technical Note:
Volumetric computed tomography for radiotherapy simulation and treatment planning. J
Appl Clin Med Phys. July 2021. doi:10.1002/acm2.13336. This article was published
under an open access agreement.
In Chapter 3, I demonstrated the reduction in respiratory motion artifacts when 4D-CT
imaging was performed on a volumetric CT scanner. I also quantitatively evaluated the
impact of this reduction in motion artifacts on contouring in images of a motion phantom
and patients with NSCLC. In phantom 4D-CT images, target contours were significantly
smaller and less variable in v4D-CT images relative to clinical 4D-CT images. In patient
images, the mean Hausdorff distance metric measuring the difference between contours on
v4D-CT and clinical 4D-CT images was significantly related to the respiratory phase,
indicating that motion artifacts contributed to these differences. This article is in
preparation for submission to the journal Medical Physics by Young HM, Kempe J, Lee
TY, Gaede S.
In Chapter 4, I developed a pipeline to generate lung ventilation, perfusion, and V/Q images
from a single, contrast-enhanced imaging protocol using a volumetric CT scanner. I then
demonstrated the feasibility of this protocol in two patients with NSCLC before and 6
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weeks after conventional radiation therapy. Finally, I show preliminary evidence of a
validation study using xenon-enhanced CT and

68

Ga-labelled MAA PET perfusion in

anesthetized pigs. The feasibility of this protocol was demonstrated in the target patient
population, and this method identified changes in the irradiated lobe of both patients 6
weeks after radiation therapy. The validation evidence shows modest voxel-wise
correlations between the novel method images and their established counterparts.
In Chapter 5, a summary of the findings and conclusions of Chapters 2-4 is provided, and
a discussion of limitations of the work. Finally, the future studies that are planned to build
on this work are presented.
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CHAPTER 2

2

Volumetric Computed Tomography for Radiotherapy
Simulation and Treatment Planning

We measured several quality metrics in phantom scans performed on a 256-slice
volumetric CT scanner to assess the utility of volumetric CT for radiotherapy simulation
and treatment planning. The results of the study showed that artifacts potentially
introduced by volumetric CT imaging are mitigated by the scanner, and no clinically
significant artifacts were observed. This study demonstrates the utility of volumetric CT
for radiotherapy simulation, which can have an important clinical impact by greatly
reducing the presence of 4D-CT motion artifacts that have been shown to negatively impact
patient outcomes.
The contents of this chapter were previously published in the Journal of Applied Clinical
Medical Physics: Young HM, Park CK, Chau O-W, Lee T-Y, Gaede S. Technical Note:
Volumetric computed tomography for radiotherapy simulation and treatment planning. J
Appl Clin Med Phys. July 2021. doi:10.1002/acm2.13336. This article was published
under an open access agreement.

2.1 Introduction
Four-dimensional computed tomography (4D-CT) is part of the standard of care for
radiotherapy treatment planning for tumours influenced by respiratory motion, such as in
lung and liver cancer. Lung and liver tumours have been shown to move up to 50 mm
during free breathing1,2. However, conventional CT scanners have a narrow axial field-ofview (aFOV) of 40mm or less, so images must be acquired at multiple couch positions and
recombined to construct a complete image set. Irregular breathing motion during this
acquisition can result in significant motion-induced artifacts3. These artifacts may lead to
inaccuracies in target delineation and contouring organs at risk due to geometric
distortion4,5, and have been shown to significantly impact clinical outcomes in patients with
lung and liver lesions6.
New volumetric CT scanners (also called area detector scanners) with 160 mm aFOV
greatly reduce the artifacts caused by irregular breathing motion during imaging7.
However, accurate CT density measurements are critical for radiation dose calculations,
and the volumetric geometry used in vCT may result in cone beam artifacts which could
distort the measured CT number. This effect could limit the application of vCT for radiation
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treatment planning and dose calculations. Previous studies have investigated image quality
metrics in other scanners, finding evidence of cone-beam artifacts that were not clinically
significant8. In addition, one recent study investigated dose and effective energy in a
160mm aFOV scan in a volumetric scanner9.
The objective of this study is to examine the image quality of vCT images acquired on the
GE Revolution CT scanner across multiple axial fields-of-view using a Catphan 504
phantom (The Phantom Laboratory Inc., Greenwich, USA). CT number linearity,
uniformity, noise, and low-contrast resolution were assessed across increasing aFOV.
Furthermore, we generated relative electron density (RED) curves for clinical
implementation in radiotherapy treatment planning systems.

2.2 Materials and Methods
2.2.1

Image Acquisition

The Catphan 504 phantom was imaged on a 256-slice GE Revolution volumetric CT
scanner (GE Medical Systems, Madison, USA) at 120 kV, 590 mA, 0.625 mm pixel
spacing, and 1.0 s rotation speed with 980 projections. Images were reconstructed with the
“Standard” convolution kernel and the filter type “Medium Filter”, with a cut-off frequency
(5% MTF) of 8 lp/cm. Repeated scans with aFOV of 40, 80, 120, 140, and 160 mm were
performed, and the entire phantom was scanned in axial mode for each aFOV. Phantom
specifications for expected CT number and relative electron density (RED) for the phantom
density inserts were taken from the Catphan 504 manual10. summarized in Table 2-1. To
test for changes in image uniformity along the z-axis, the Catphan was imaged with an
aFOV of 160 mm positioned in the center of the bore, and at the outer edges of the scanner.
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Table 2-1 Catphan 504 phantom density insert measurements
Mean CT number measured in circular regions in the Catphan 504 phantom density inserts.
Expected CT number given as [minimum, maximum] and relative electron density (RED)
given in the Catphan manual.
Measured CT Number [HU]
Expected CT
Material

40 mm

80 mm

120 mm

140 mm 160 mm

Number [HU]

Teflon

889.01

890.37

900.94

904.68

904.86

[941, 1060]

1.868

Delrin

302.44

306.08

311.66

316.84

317.18

[344, 387]

1.363

Acrylic

121.68

120.89

120.48

121.21

120.13

[92, 137]

1.147

Polystyrene

-36.4

-36.3

-36.3

-35.8

-37.2

[-65, -29]

0.998

LDPE

-94.41

-92.85

-94.4

-93.15

-93.1

[-121, -87]

0.945

PMP

-187.45

-185.72

-185.8

-185.21

-185.61

[-220, -176]

0.853

Air

-995.73

-992.53

-992.24

-992.2

-990.92

[-1046, -986]

0.001

RED

LDPE = Low-density polyethylene; PMP = Polymethylpentene

2.2.2

Image Analysis

Image analysis for CT number measurements including linearity, uniformity, noise, and
low-contrast resolution was performed using ITK-SNAP (version 3.4.0)11 for all aFOV
values.
2.2.2.1 Linearity
Linearity was measured by measuring the average CT number in a region of interest (ROI)
within the sensitometry (CTP404) module in inserts containing Teflon, Delrin, acrylic,
polystyrene, low-density polyethylene (LDPE), polymethylpentene (PMP), and air as
shown in Figure 2-1. These values were compared to the expected range given in the
Catphan manual.
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Figure 2-1 Axial CT images of Catphan 504 phantom modules analyzed using ITK-Snap
(A) The sensitometry module used for linearity measurements containing (i) Teflon, (ii)
Delrin, (iii) acrylic, (iv) polystyrene, (v) LDPE, (vi) PMP, and (vii) air density inserts
(window width/window level = 600/0 HU). (B) The uniformity (CTP486) module used to
measure uniformity and noise (window width/window level = 600/0 HU). (C) The lowcontrast resolution (CTP515) module used to measure contrast-to-noise (CNR) in the (i)
1.0% and (ii) 0.5% nominal contrast level targets (window width/window level = 120/20
HU).
2.2.2.2 CT Number Uniformity
CT number uniformity across an image was evaluated using the phantom uniformity
(CTP486) module using circular ROIs (area = 520 mm2) manually placed in the centre of
the phantom (1 ROI) and at the periphery of the phantom (4 ROIs) as described in the
phantom manual. The mean intensity was measured in each ROI, and the absolute
difference between the centre region and maximum periphery region was calculated using
Equation 2-1:
Equation 2-1
𝑀𝑎𝑥 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 = N𝐶𝑇-%'),/%)!%( − 𝐶𝑇-'*,0%("01%(+ N
The CT number [HU] difference measured in the uniformity module is expected to be
within 2% (20 HU) of that of water, usually in the range 5 – 18 HU10.
To test image uniformity in the z-direction, horizontal image profiles were taken across a
uniform region of the phantom positioned at the outer edges of the scanner bore and in the
center. These profiles were visually examined for artifacts. A longitudinal profile was also
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taken in a uniform region of the phantom, to evaluate possible correlations between CT
number and position on the z-axis.
2.2.2.3 Image Noise
Image noise was quantified by measuring the standard deviation of the CT number within
a circular ROI (area = 2500 mm2) in the uniformity module.
2.2.2.4 Low-Contrast Resolution
Low-contrast resolution was assessed using three nominal target contrast levels of 1.0%,
0.5%, and 0.3%. For each level, an image from the low-contrast (CTP515) module was
displayed with fixed image settings (window=400, level=40). Three independent observers
manually counted the number of targets visible in the image. The viewing conditions
including the computer screen and location brightness, and physical environmental
surroundings were kept constant.
2.2.2.5 Contrast-to-Noise Ratio (CNR)
To measure CNR, targets were selected in the 1.0% and 0.5% contrast regions in the lowcontrast module, and two background targets of the same size (area = 90 mm2) were
selected adjacent to the targets, as shown in Figure 2-1. CNR was measured according to
Equation 2-2 below:
Equation 2-2
2(𝐶2 − 𝐶3 )4
𝐶𝑁𝑅 =
𝜎2 − 𝜎3
Where 𝐶2 and 𝜎2 are the mean and standard deviation of the signal from the target, and 𝐶3
and 𝜎3 are the mean and standard deviation of the signal from the background.
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2.2.2.6 RED Calibration Curves
RED calibration curves for each aFOV were generated by plotting the measured CT
number and the known RED obtained from the Catphan 504 phantom manual as shown in
Table 2-1.

2.2.3

Statistical Analysis

All statistical analysis was performed using Prism 7.0 (GraphPad Software Inc., California,
USA). Spearman correlation coefficient (ρ) was used to assess correlations between
measured parameters and aFOV, and linear regression was used to assess the strength of
significant correlations.

2.3 Results
2.3.1

Linearity

The measured CT number for all aFOV was within the range specified in the Catphan 504
manual for air, PMP, LDPE, polystyrene, and acrylic. CT number was underestimated at
all aFOV settings for the two high-density inserts: Delrin and Teflon. All CT number
measurements are shown in Table 2-1.
Measured CT number was significantly correlated with aFOV in Teflon (ρ = 1.0, p = 0.02,
r2 = 0.92), Delrin (ρ = 1.0, p = 0.02, r2 = 0.97) and air (ρ = 1.0, p = 0.02, r2 = 0.83) with a
significantly non-zero slope (Teflon: p = 0.01, Delrin: p = 0.002, air: p = 0.03), as shown
in Figure 2-2. Measured HU and aFOV were not significantly related for acrylic (ρ = -0.7,
p = 0.2), polystyrene (ρ = -0.05, p = 0.9), LDPE (ρ = 0.4, p = 0.5), or PMP (ρ = 0.8, p =
0.1).
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Figure 2-2 Difference between measured CT number in the sensitometry (CTP404)
module and the expected CT number for each aFOV in the vCT images.
CT number and aFOV were not significantly correlated for: acrylic (ρ = -0.7, p = 0.2),
polystyrene (ρ = -0.05, p > 0.99), LDPE (ρ = 0.4, p = 0.5), and PMP (ρ = 0.8, p = 0.1).
Measured CT number was significantly correlated with aFOV for: Teflon (ρ = 1.0, p =
0.02, r2=0.92), Delrin (ρ = 1.0, p = 0.02, r2=0.97), and air (ρ = 1.0, p = 0.02, r2=0.83).

2.3.2

Uniformity

The average CT number in each uniformity ROI across all aFOV images was (10.8 +/- 1.2)
HU (A), (11.3 +/- 0.7) HU (B), (9.9 +/- 0.4) HU (C), (8.6 +/- 0.6) HU (D), and (9.9 +/- 0.5)
HU (E). The mean measured CT number in all ROIs was within 2% (20 HU) of the
expected value (0 HU). The maximum absolute difference in CT number between central
and peripheral ROIs was (2.1 +/- 1.1) HU and < 5 HU for all measurements. The maximum
absolute difference in CT number was not significantly correlated with aFOV (r=0.235,
p=0.7), as shown in Figure 2-3.

2.3.3

Noise

Noise in the uniformity module for all aFOV values was 4.6 +/- 0.04 HU. Noise was not
significantly correlated to aFOV (ρ =-0.4, p=0.4), as shown in Figure 2-3.
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2.3.4

Low-Contrast Resolution
Three independent observers counted the number of targets in the low-contrast

resolution module at contrast levels 1.0%, 0.5%, and 0.3% for each aFOV. The number of
observed targets was 8.7 +/- 0.5 at 1.0%, 6.7 +/- 0.4 at 0.5%, and 0.33 +/- 0.4 at 0.3%, as
shown in Figure 2-3. Number of observed targets was not significantly correlated with
aFOV at 1.0% (p = 0.067), 0.5% (p = 0.2), or 0.3% (p > 0.99).
Contrast-to-noise ratio (CNR) was analyzed on the low-contrast resolution image (Figure
2-1) using the 15 mm targets in the 1.0% and 0.5% nominal contrast levels. The CNR at
1.0% was 5.2 +/- 0.9 and at 0.5% was 1.6 +/- 0.6. CNR was not significantly related to
aFOV at 1.0% (ρ = 0.4, p = 0.5) or 0.5% (ρ = -0.3, p = 0.7), as shown in Figure 2-3.
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Figure 2-3 Correlation between image quality metrics and aFOV
(A) Maximum absolute difference [HU] between central and peripheral ROIs vs axialfield-of-view (aFOV) in the uniformity (CTP486) module (ρ = 0.20, p = 0.78). (B) Mean
number of observed targets counted by three independent observers vs aFOV in the lowcontrast (CTP515) module at contrast levels: 1.0% (ρ = 0.95, p = 0.067), 0.5% (ρ = 0.87,
p = 0.20), and 0.3% (ρ = 0.22, p > 0.99). (C) Noise in the uniformity ROI vs aFOV in the
uniformity (CTP486) module (ρ = -0.35, p = 0.40). (D) Contrast-to-noise ratios (CNR) in
nominal contrast levels 1.0% and 0.5% vs aFOV in the low-contrast (CTP515) module (ρ
= 0.40, p = 0.52 (1.0%), ρ = -0.30, p = 0.68 (0.5%)).

2.3.5

Longitudinal Directional Dependence

Horizontal profiles were compared from images taken at the center of the imaging bore of
the scanner and at the outer edges of the bore at 160mm aFOV. The profiles were plotted
as shown in Figure 2-4. No visible artifacts were identified, and there were no visible
differences between the profiles. In the longitudinal profile, shown in Figure 2-4, there was
no significant correlation between z position and measured CT number (ρ = 0.04, p = 0.8).
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Figure 2-4 Horizontal and Vertical Catphan profiles
(A) Horizontal profiles of a uniform volume in the Catphan 504 phantom taken when the
phantom was in a superior, center, and inferior position along the z-axis. These profiles
appear to be consistent across the imaging volume. (B) A longitudinal profile of the
uniform acrylic perimeter of the Catphan phantom. There is no significant relationship
between measured CT number and position within the imaging bore (ρ = 0.04, p = 0.8).
Slices from the linearity module acquired at each aFOV value were also compared by
visual inspection and by comparing line profiles through each image, as shown in Figure
2-5. There were no visible differences between the images from each aFOV
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Figure 2-5 Comparison of images across aFOV
An axial slice of the linearity module in the Catphan 504 phantom acquired at each aFOV
value tested in this study, and longitudinal profiles from each image. Visual comparison
shows no obvious differences between the images.

2.3.6

RED Calibration

To perform dose calculations using a CT image, a relative electron density (RED) curve
specific to the CT scanner and imaging parameters is required. We generated RED curves
for each image set, shown in Figure 2-6.
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Figure 2-6 Relative electron density curves
Relative electron density (RED) calibration curves of measured CT number against
Catphan 504 Phantom RED specifications for aFOV of 40 mm, 80 mm, 120 mm, 140 mm,
and 160 mm on the vCT, and for the clinical CT. All RED curves were highly correlated
(ρ = 1.0, p = 0.0004).

2.4 Discussion
In this paper, we assessed the utility of volumetric CT for radiotherapy simulation,
treatment planning, and dose calculation. Volumetric CT is particularly useful for dynamic
imaging techniques, such as contrast-enhanced imaging and 4D-CT, both of which are used
in radiation treatment planning. Previous research has investigated the impact of
volumetric imaging on these dynamic techniques, and has demonstrated that contrastenhanced imaging is not negatively affected by cone-beam artifacts in volumetric
imaging9,12 and vCT can reduce the presence of respiratory motion artifacts in 4D-CT used
for motion management7. These findings support the potential use of vCT for treatment
planning.
We investigated the differences in linearity, RED, noise, and uniformity of images acquired
using a 256-slice vCT scanner at different aFOV settings. The measurements were
compared to the Catphan 504 phantom manual to determine if any artifacts were present
that could impact the use of this scanner for CT simulation and radiation therapy planning.
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We also imaged the phantom at different locations along the longitudinal axis of the
scanner to test for cone-beam artifacts.
Our measurements demonstrated that measured CT number in acrylic, polystyrene, LDPE,
PMP and air were consistent with the values expected from the Catphan manual (Table 11). However, measured CT number in Teflon and Delrin were underestimated for each
axial coverage compared to these specifications. CT density is dependent on various factors
including energy, scattering, and reconstruction algorithms13,14. The phantom
specifications are defined over 94 different scanners and protocols, and the manual
explicitly states that dramatic deviations from the specified HU range are not unusual10. In
addition, a single scanner is known to produce variable results over time15, and this
variability is expected and accounted for in commissioning and quality assurance
protocols. For treatment planning purposes, these variations will be accounted for with the
relative electron density curve that is specific to the scanner. Therefore, while these
deviations are statistically significant, we do not expect them to be clinically significant.
We also observed that measured CT number in acrylic, polystyrene, LDPE, and PMP were
not significantly correlated to aFOV, but Teflon, Delrin, and air increased significantly
with aFOV. However, the relative change in CT number was small in all these cases (<5%
for Delrin, and <1% for all lower density materials). These results suggest that most
artifacts of increased aFOV are mitigated by hardware (ie. an anti-scatter grid) and
algorithms to reduce artifacts in reconstructed images on the CT scanner. In addition, any
remaining artifacts are so small that they are not considered clinically significant.
Uniformity measurements were in agreement with the recommended range16 for each
aFOV measured and were not significantly correlated with aFOV. Noise was also not
correlated with aFOV. In our low-contrast resolution test there was strong agreement
between our observers, and the number of targets identified was not significantly related
to aFOV. CNR was analyzed for the 1.0% and 0.5% contrast modules and was also not
significantly related to aFOV.
This study is limited by the fact that only phantom images were studied. Anthropomorphic
phantoms or human images can also be compared between a clinical and volumetric
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scanner to confirm these findings. In addition, it is noteworthy that the relatively small bore
size of this scanner (80 cm) limits its use for radiation therapy planning for some patients.
Most clinical CT simulators are wide-bore scanners to accommodate a range of patient
sizes and to include immobilization equipment, which can be very bulky. The small bore
of the scanner in this study means that it likely cannot meet all CT simulation needs, as a
large bore scanner will be needed for some patients. In the future, large-bore volumetric
CT scanners could enable wider use of this technology in radiation oncology.
These results have significant implications for future clinical research projects. Dynamic
contrast-enhanced CT imaging with a vCT scanner enables high-resolution functional
mapping over a large anatomical volume. This advanced imaging technique can facilitate
research projects such as functional avoidance treatment planning or studying imaging
biomarkers of treatment response. The use of a vCT scanner for treatment planning
facilitates direct access for researchers to volumetric imaging for research studies. Further
work must be done to fully characterize the RED in clinical conditions before this system
can be used clinically, in accordance with AAPM recommendations16,17.

2.5 Conclusions
We imaged a Catphan phantom on a vCT scanner to assess image quality and generated
RED calibration curves for increasing axial coverage up to 160 mm. CT linearity,
uniformity, noise, and low-contrast resolution were within the expected range for most
measurements, and deviations were determined to be not clinically significant. Our results
suggest that most artifacts resulting from increased aFOV are mitigated by reconstruction
techniques on the scanner, and remaining artifacts are considered clinically acceptable for
radiation treatment planning. This study demonstrates that the vCT scanner can be used
for CT simulation and radiotherapy treatment planning.
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CHAPTER 3

3

Reduction of respiratory motion artifacts using volumetric
four-dimensional computed tomography

Four patients with non-small cell lung cancer and a motion phantom underwent clinical
4D-CT imaging on a conventional scanner and 4D-CT on a volumetric CT scanner (v4DCT) which was used to simulate a conventional acquisition (sim4D-CT). The clinical 4DCT phantom contours were significantly larger than the v4D-CT contours, suggesting an
over-estimation of target size, and the differences between clinical contours in patient
clinical 4D-CT and v4D-CT were significantly correlated with the respiratory phase,
suggesting that motion artifacts contributed to this difference. These results demonstrate
that v4D-CT reduces motion artifacts, decreasing contour variability throughout the
respiratory cycle.
The contents of this chapter are in preparation for submission to the Journal of Medical
Physics by: HM Young, J Kempe, TY Lee, and S Gaede.

3.1 Introduction
Radiation treatment planning for non-small cell lung cancer (NSCLC) is often complicated
by the respiratory motion of the tumors and surrounding organs at risk (OARs). To ensure
sufficient dose is delivered to the tumor, and OARs are spared, motion management
techniques are necessary. Four-dimensional computed tomography (4D-CT) is an
important part of the treatment planning process in which the motion of the tumor is
quantified, and anatomical images for treatment planning are acquired. However, 4D-CT
images are prone to artifacts caused by irregular breathing motion1. These artifacts have a
negative impact on contouring of the target and surrounding organs at risk2–7 and have even
been shown to reduce local control after stereotactic radiation therapy to the lung or liver8.
Various methods have been developed to mitigate the effects of irregular breathing on 4DCT image quality. Some methods use improved image sorting and reconstruction
algorithms9,10. This approach is limited due to a lack of image data, in an effort to limit the
radiation dose from imaging. Other methods use motion tracking to improve data
acquisition on the scanner, by turning off the x-ray beam when breathing motion is outside
the expected range11. This method has been shown to be feasible for clinical use and
reduces visibly obvious motion artifacts12,13. However, artifacts remain in some images.
Other studies have investigated methods which require a significantly higher imaging dose,
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such as an oversampling acquisition14. This method reduces motion artifacts, but the
increased imaging dose limits its applicability.
Volumetric CT scanners can overcome these limitations by implementing a wide-area
detector (160mm axial field-of-view) so a large volume can be imaged in a single rotation.
Therefore, a treatment planning 4D-CT scan can be acquired in two to three couch
positions, so variation in respiratory motion between slices is limited. In addition, these
scanners employ a faster rotation time (0.28s) than many clinical CT scanners to date,
which minimizes blurring due to motion. This technology may enable the acquisition of
4D-CT with few or no respiratory motion artifacts if the patient is positioned such that the
motion of the target is captured within the 160 mm aFOV. This would enable more accurate
contouring, which can increase the dose delivered to the target, and decrease the dose
delivered to surrounding healthy tissue. In addition, this technology will enable the
acquisition of dynamic functional imaging across a large volume, which can be used to
study functional properties of the tumor or surrounding tissue before treatment, or to assess
treatment response.
The objective of this study is to quantify the reduction in respiratory motion artifacts by
using a volumetric CT scanner. To control for daily variations in patient breathing, we also
simulated a conventional 4D-CT acquisition using volumetric CT images to induce motion
artifacts. The images were compared visually, and quantitative analysis of contours of a
phantom target and patient OARs was performed across image types and respiratory
phases.

3.2 Materials and Methods
3.2.1

Image Acquisition

3.2.1.1 Phantom Study
For this study, we used the Quasar Programmable Respiratory Motion Phantom (Modus
Medical Devices, London Canada), shown in Figure 3-1. This phantom consists of an
acrylic thorax-shaped phantom containing a customized moving cedar insert, which
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contains 4 polystyrene spheres (with known diameter). The largest polystyrene sphere also
contains implanted gold VISICOIL markers (IZI Medical, Owings Mills, USA). The
phantom was programmed to move with 3 different motion traces: (1) Sinusoidal motion
(20 mm peak-to-peak amplitude, 4.0 s period), (2) a patient-derived motion trace
demonstrating a baseline drift artifact (initial amplitude 15 mm, maximum drift 12.8 mm),
and (3) a patient-derived motion trace demonstrating an irregular amplitude artifact
(minimum amplitude = 5 mm, maximum amplitude = 25 mm). The moving phantom was
imaged on a GE Revolution 256-slice volumetric CT scanner (GE Healthcare, Milwaukee,
USA), and on a Philips Brilliance Big Bore 16-slice CT simulator (Philips Healthcare,
Fitchburg, USA). The image acquisition details are shown in Table 3-1.

Figure 3-1 Quasar programmable respiratory motion phantom used for all phantom
imaging.
(A) Photo of the Quasar phantom set up on the bed of the volumetric CT scanner before
imaging. (B) Axial, (C) Sagittal, and (D) Coronal slices from a single volumetric CT image
of the phantom. No marker block was used for this scan, motion tracking and phase binning
was performed using the VISICOIL marker indicated by the arrows in (B), (C), and (D).
3.2.1.2 NSCLC Patient Study
Four NSCLC patients received standard of care clinical 4D-CT simulation on a Philips16slice CT scanner and received a free breathing CT scan on the research 256-slice CT
scanner. The image acquisition details for both scanners are shown in Table 3-1. On the
clinical scanner, chest motion was captured simultaneously during image acquisition by
the Varian RGSC system (Varian Medical Systems, Palo Alto, USA) and used to
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reconstruct the images into 10 breathing phases. The volumetric 4D-CT research scan was
acquired as part of another research study (NCT03416972) and included an iodine-based
contrast administered approximately 10 seconds after the beginning of the dynamic CT
scan.
Table 3-1 Scan parameters for all image acquisitions
Scanner Mode
Rotation
aFOV
Voltage
Speed [s] [mm]
[kV]

Current
[mA]

Scan
time [s]

vCT

cine

0.28

160

120

100

10

vCT

cine

0.28

160

120

10

45

Clinical

helical

0.5

24

120

97

30-120

3.2.1.3 Simulated Conventional 4D-CT from Volumetric CT Images
The volumetric images that were acquired using an aFOV of 160mm were retrospectively
resampled and sorted to simulate image acquisition with a narrow aFOV of 20mm and a
cine-mode acquisition using in-house software, as shown in the schematic in Figure 3-2.
First, a semi-automated edge detection method was used to extract diaphragm motion from
the images. An edge detection filter was applied to a manually defined region of interest,
and thresholding was used to identify the curve of the diaphragm. The peak of this curve
was used to define diaphragm position. This motion was used as a surrogate for the external
chest motion data to simulate the respiratory trace captured by the Varian RGSC system in
the clinical 4D-CT scan. The diaphragm position data was interpolated using spline
interpolation in MATLAB, and end-inhale phases were manually identified in this motion
trace. The volumetric images were sorted by phase-based binning using the internal motion
data. To mimic cine-mode acquisition using 8 s per couch position and a 20mm aFOV,
only the images acquired within an 8 s time window at a simulated couch position were
used and the remainder discarded. To ensure there was enough time series data, we looped
from the last acquired imaging set to the first acquired imaging set. No slices were
duplicated in this process since the first 40s of the simulated scan contained only slices
from the superior half of the image dataset and the remaining scan contained only slices
from the inferior half of the image dataset. From theses remaining images, volumes were
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reconstructed at 10 respiratory phases using in-house software to create a simulated
conventional 4D-CT (sim4D-CT).

Figure 3-2 Workflow of method used to generate sim4D-CT images from volumetric CT
images.

3.2.2

Image Analysis

3.2.2.1 Phantom Study
The largest polystyrene sphere implanted in the phantom was manually segmented on
every phase of each 4D-CT image set ITKSnap15, and the volume of each contour was
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measured. The mean and standard deviation of these volumes were compared between scan
types using a one-way ANOVA and Bartlett’s test. These measured volumes were
compared to the known volume of 1.41 x 104 mm3. Any contour which was within 5% of
the known volume was deemed acceptable, and those which deviated by more than 5%
were considered unacceptable. Then, using only the v4D-CT images, a thresholding
method was used to automatically detect the motion of the implanted gold marker in the
phantom throughout the scan. This measured position was compared to the input motion
trace at each timepoint using Pearson correlation for each motion type. The images were
also assessed qualitatively for differences between each scan type.
3.2.2.2 Patient Study
First, the images were assessed qualitatively for differences between each scan type.
Contours for organs at risk (left and right lung, bronchi, trachea, and spinal cord) were
delineated using a commercial deep-learning based auto-contouring program (Limbus AI,
Regina, Canada) with some manual corrections on all phases of all 4D-CT images. The
heart was not included in this study because the cardiac motion presents an additional
source of artifacts. For each phase and each patient, the clinical and sim4D-CT images
were rigidly registered to the v4D-CT image in 3DSlicer16 (version 4.10.2). The contours
for each image were compared using the Dice coefficient and mean Hausdorff distance
with the Segment Comparison tool in 3DSlicer. For long tube-like structures, including the
bronchial tree and spinal cord, only the mean Hausdorff distance was calculated, as it is
the more appropriate metric for that type of structure.

3.2.3

Statistical Analysis

Phantom contours volumes were compared across the three scan types using a one-way
ANOVA and Dunnett’s multiple comparisons test. Bartlett’s test was used to test if the
standard deviation of each measurement was different across the three scan types.
To evaluate the changes in patient contours as a function of phase, which is cyclical and
often measured as a percentage of the cycle, the measure of phase was converted as shown
in Equation 3-1 below to establish a linear relationship.
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Equation 3-1
𝑃ℎ𝑎𝑠𝑒#") = 𝑠𝑖𝑛(𝑃ℎ𝑎𝑠𝑒)
The highest value of Phasesin corresponds to the end-exhale and early inhale phase of the
respiratory cycle and the lowest value corresponds to the mid-exhale phase. Relationships
between Mean Hausdorff distance and Dice coefficient were compared to phase using the
Pearson correlation coefficient. All statistical tests were performed using GraphPad Prism
(version 9.3.1).

3.3 Results
3.3.1

Phantom Study

3.3.1.1 Qualitative Results
The clinical 4D-CT, v4D-CT, and sim4D-CT images of the Quasar respiratory motion
phantom were all compared qualitatively for the presence of visually obvious motion
artifacts. A subset of images showing this comparison is shown in Figure 3-3. In the v4DCT images, no visually obvious motion artifacts were visible in any of the images.
However, in the sim4D-CT and v4D-CT images there were several motion artifacts seen
in each scan. In the Baseline Drift and Irregular Motion scans there were artifacts which
distorted the size and shape of the spherical inserts, mostly in the mid-inhale and midexhale phases of the respiratory cycle. Artifacts were not visible at the end-exhale phase.
and in the sinusoidal motion scan there was primarily blurring visible in the mid-inhale and
mid-exhale phases.
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Figure 3-3 Images of the Quasar Motion Phantom from clinical and volumetric 4D-CT.
Images of Quasar respiratory motion phantom from v4D-CT (first column), sim4D-CT
(second column) and clinical 4D-CT (third column) scans under baseline drift (first row)
irregular amplitude (second row) and sinusoidal (third row) motion conditions. All images
are mid-exhale images taken from a 4D-CT scan. While there were no visually obvious
motion artifacts present in the v4D-CT images, there were visible motion artifacts in the
sim4D-CT and clinical 4D-CT images under all motion conditions.
3.3.1.2 Quantitative Results
For the volumetric CT scan under all motion conditions, the contours were within 5% of
the known volume of the phantom sphere. For the simulated clinical 4DCT images under
all motion conditions, only 30% of the contours were within 5% of the known volume.
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47% of the contours were above the known volume, and the remaining 23% were below.
For the clinical scanner under all motion conditions, only 7% of the contours were within
5% of the known volume. 80% of contours were above the known volume, and the
remainder were below the known volume.
There was not a significant difference found between the mean volumes measured in the
baseline drift scan, but there were significant differences found in the irregular amplitude
(p = 0.02) and sinusoidal (p < 0.0001) scans. Bartlett’s test showed significantly different
standard deviations between the groups for baseline drift (p < 0.0001), irregular amplitude
(p < 0.0001), and sinusoidal motion (p = 0.002). These results are shown in Figure 3-4.
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Figure 3-4 Phantom contour volume across motion conditions and scan type.
Contour volume of a spherical target in the Quasar respiratory motion phantom across three
motion conditions using v4D-CT, sim4D-CT and clinical 4D-CT measured at each
respiratory phase. There was no significant difference between mean measured volume
between scan types under baseline drift motion. There was a significant difference in mean
volume between v4D-CT and clinical 4D-CT under irregular amplitude (p = 0.02) and
sinusoidal motion conditions (p < 0.0001), but not between v4D-CT and clinical 4D-CT.
There was a significant difference in the standard deviation of the measures across scan
types for all three motion conditions, resulting in the high variation in contour volume seen
in the sim4D-CT and clinical 4D-CT plots above.
The measured position of the gold marker in the v4D-CT images was highly correlated
with the known phantom position for all motion patterns (baseline drift: r=0.997, p<.0001;
irregular amplitude: r=0.997, p<.0001; sinusoidal: r=0.998, p<.0001). These results are
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shown in Figure 3-5. Both the size and motion of the sphere were determined with high
accuracy in all v4D-CT scans.

Figure 3-5 Phantom motion input and measured phantom position in v4D-CT images.
Plots of measured marker position taken from vCT images of the motion phantom
(markers), plotted with the input motion trace to the phantom (solid line). Correlation
between these two measurements is given for (A) Baseline Drift scan (r = 0.997, p <
0.0001), (B) Irregular Motion scan (r = 0.997, p < 0.0001), (C) Sinusoidal scan (r = 0.998,
p < 0.0001).
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3.3.2

Patient Study

3.3.2.1 Qualitative Results
For all patients, there were no visually obvious motion artifacts present in the volumetric
4D-CT images. Motion artifacts were seen in at least one phase of the sim4D-CT images
and clinical 4D-CT images for all patients. These were most commonly seen in mid-inhale
and mid-exhale images, and in these four patients no motion artifacts were observed in the
end-exhale image. Representative images for each imaging type for each patient are shown
in Figure 3-6. Within a single patient, artifacts in sim4D-CT images and artifacts in the
corresponding phase of the clinical 4D-CT often occur in the same anatomical region. It
should be noted that the entire iodine contrast-enhanced image series from the v4D-CT
imaging was used to generate the sim4D-CT images. This means that the contrast is visible
in some of the sim4D-CT images.
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Figure 3-6 Mid-exhale images from each patients’ 4D-CT images
Each column contains the images from a single patient, as labelled. The volumetric 4D-CT
images (top row) have no visible blurring or motion artifacts. The simulated conventional
4D-CT images (center row) contain some motion artifacts, indicated by white arrows. The
clinical 4D-CT images (bottom row) contain several motion artifacts, indicated by black
arrows.
3.3.2.2 Quantitative Results
When comparing the OAR contours between the v4D-CT images and the clinical 4D-CT
images, the agreement between contours of the same organ varied throughout the breathing
cycle. Contours were compared to Phasesin such that the highest value of Phasesin
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corresponds to the end-exhale and early inhale phase of the respiratory cycle and the lowest
value corresponds to the mid-exhale phase. There was a significant correlation between
Phasesin and the mean Hausdorff distance between the bronchial tree (r = -0.84, p = 0.002)
and trachea (r = -0.86, p = 0.001) contours. There was no significant correlation between
Phasesin and mean Hausdorff distance between the spinal cord contours (r = 0.04, p = 0.9),
as the spinal cord undergoes very little respiratory motion in the supine position. There
was also a significant correlation between Phasesin and the Dice coefficients and mean
Hausdorff distance between the right lung (r = 0.95, p < 0.0001; r = -0.90, p = 0.0004)
contours. There was no significant relationship between Phasesin and measures of the left
lung contours. These results are shown in Figure 3-7.
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Figure 3-7 Dice and Hausdorff distance comparisons of organs at risk from v4D-CT and
clinical 4D-CT scans of four patients with non-small cell lung cancer.
Mean Hausdorff distance between the bronchial tree, trachea, and right lung were
significantly correlated to sin(Phase). The Dice coefficient between the right lung contours
was also significantly correlated to sin(Phase).
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When comparing OAR contours between the v4D-CT images and the sim4D-CT images,
the measures showed the same trends relative to respiratory phase, but the correlations were
weak and were not statistically significant.

3.4 Discussion
In the sim4D-CT and clinical 4D-CT phantom images, the observed motion artifacts
distorted the size and shape of the spherical markers. This finding was expected, as it has
been clearly documented in previous studies that motion artifacts can significantly impact
the contouring of the target in radiation therapy2–6. This idea is strengthened by the
phantom contour results, where v4D-CT images produced accurate volumetric
measurements of the spherical marker while the sim4D-CT and clinical 4D-CT images did
not. In addition, the marker motion in the v4D-CT images was highly correlated to the
known motion. This demonstrates clearly that the size and motion of a potential target can
be clearly measured using v4D-CT while clinical 4D-CT is known to perform poorly in
this task.
The impact of motion artifacts on contouring was again demonstrated in the patient contour
results, as agreement between OAR contours between v4D-CT and clinical 4D-CT scans
varied by respiratory phase. This is likely due to the increased presence of artifacts at midinhale and mid-exhale phases. There was no significant correlation between measures of
v4D-CT and sim4D-CT with phase. This may be because fewer artifacts were present in
the sim4D-CT images, and the inherent relationship between the images as they were
created from the exact same data set. In addition, the faster rotation speed of the volumetric
scanner results in decreased blurring due to motion, and this factor is present in both the
v4D-CT and sim4D-CT images.
The reduced variability of contour volumes in v4D-CT relative to clinical 4D-CT
demonstrated here suggests that v4D-CT can enable more precise dose calculations and
delivery of radiation to the target. In addition, motion artifacts can impact organ-at-risk
contouring, radiation dose calculations, matching with cone-beam CT (CBCT) for image
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guidance. The reduction of motion artifacts shown in this study may have implications for
clinical and research applications of dynamic CT imaging.
Artifacts also have a significant impact on CT ventilation17 imaging which is currently used
in clinical trials to map high- and low-functioning regions of the lung for functional
avoidance treatment planning. The current high rate of artifacts in clinical 4D-CT is one
reason that there is ongoing debate as to whether functional-guided radiation therapy
should be used clinically18. Future work in this area will include direct comparison on CT
ventilation maps derived from clinical, volumetric, and sim4D-CT images.
It should be noted that in the simulated 4D-CT images, an aFOV of 20 mm was used, as it
was the closest match to the clinical 4D-CT scanner and allowed us to sample the entire
aFOV of the vCT images. However, the clinical 4D-CT images were collected with an
aFOV of 24 mm, so the two image sets cannot be exactly compared. In addition, the v4DCT and sim4D-CT images were acquired with a 0.28s rotation speed with a cine mode
acquisition and were reconstructed in image space. The clinical 4D-CT images were
acquired with a 0.5s rotation speed with a slow helical acquisition and were reconstructed
in sinogram space. The effects of the different rotation speed, aFOV, and acquisition and
reconstruction type cannot be separated in this study. Despite this, we still demonstrate
many similar motion artifact distributions between each patient’s clinical 4D-CT and
sim4D-CT. In addition, the increase in motion artifacts present in the sim4D-CT scan as
compared to the volumetric scan clearly demonstrates the utility of volumetric CT for
generating artifact-free 4D-CT scans.
It should also be noted that there are limitations which may inhibit the use of volumetric
CT in radiation treatment planning in the short term, as outlined in previous work done by
this group19. Volumetric CT scanners are significantly more expensive than a conventional
CT simulator (usually with 16-64 slice detectors, as compared to the 256-slice detector in
a volumetric scanner), and currently have a narrower bore than is typically used to
accommodate large patients and immobilization devices in CT simulation. These
limitations may change over time but are currently relevant considerations to weigh against
the demonstrated benefits of volumetric CT scanners.
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3.5 Conclusion
4D-CT images acquired using a volumetric scanner contained no visibly obvious motion
artifacts, which were present in all clinical 4D-CT images of the phantom under irregular
motion and all patients. In the phantom images, the size, shape, and motion of the spherical
targets were measured with lower variability in the v4D-CT images than the clinical 4DCT images. In the patient images, agreement between v4D-CT and clinical 4D-CT images
was significantly correlated to the phase of the respiratory cycle being examined. Artifact
reduction using v4D-CT significantly improves target and OAR contouring, which may
impact patient outcomes.

83

3.6 References
1.

Yamamoto T, Langner U, Loo BW, Shen J, Keall PJ. Retrospective Analysis of
Artifacts in Four-Dimensional CT Images of 50 Abdominal and Thoracic
Radiotherapy Patients. Int J Radiat Oncol Biol Phys. 2008;72(4):1250-1258.
doi:10.1016/j.ijrobp.2008.06.1937

2.

Persson GF, Nygaard DE, Brink C, et al. Deviations in delineated GTV caused by
artefacts in 4DCT. Radiother Oncol. 2010;96(1):61-66.

3.

Louie A V, Rodrigues G, Olsthoorn J, et al. Inter-observer and intra-observer
reliability for lung cancer target volume delineation in the 4D-CT era. Radiother
Oncol. 2010;95(2):166-171. doi:https://doi.org/10.1016/j.radonc.2009.12.028

4.

Fredberg Persson G, Nygaard DE, af Rosenschöld PM, et al. Artifacts in
Conventional Computed Tomography (CT) and Free Breathing Four-Dimensional
CT Induce Uncertainty in Gross Tumor Volume Determination. Int J Radiat
Oncol. 2011;80(5):1573-1580. doi:https://doi.org/10.1016/j.ijrobp.2010.10.036

5.

Wikström KA, Isacsson UM, Pinto MC, Nilsson KM, Ahnesjö A. Evaluation of
irregular breathing effects on Internal Target Volume definition for lung cancer
radiotherapy. Med Phys. March 2021. doi:10.1002/mp.14824

6.

Clements N, Kron T, Franich R, et al. The effect of irregular breathing patterns on
internal target volumes in four-dimensional CT and cone-beam CT images in the
context of stereotactic lung radiotherapy. Med Phys. 2013;40(2):21904.
doi:10.1118/1.4773310

7.

Lambrecht M, Sonke J-J, Nestle U, et al. Quality assurance of four-dimensional
computed tomography in a multicentre trial of stereotactic body radiotherapy of
centrally located lung tumours. Phys imaging Radiat Oncol. 2018;8:57-62.

8.

Sentker T, Schmidt V, Ozga A-K, et al. 4D CT image artifacts affect local control
in SBRT of lung and liver metastases. Radiother Oncol J Eur Soc Ther Radiol
84

Oncol. 2020;148:229-234. doi:10.1016/j.radonc.2020.04.006
9.

Pan T, Sun X, Luo D. Improvement of the cine‐CT based 4D‐CT imaging. Med
Phys. 2007;34(11):4499-4503.

10.

Carnes G, Gaede S, Yu E, Van Dyk J, Battista J, Lee T-Y. A fully automated nonexternal marker 4D-CT sorting algorithm using a serial cine scanning protocol.
Phys Med Biol. 2009;54(7):2049-2066. doi:10.1088/0031-9155/54/7/013

11.

Keall PJ, Vedam SS, George R, Williamson JF. Respiratory regularity gated 4D
CT acquisition: concepts and proof of principle. Australas Phys Eng Sci Med.
2007;30(3):211. doi:10.1007/BF03178428

12.

Werner R, Sentker T, Madesta F, et al. Intelligent 4D CT sequence scanning
(i4DCT): First scanner prototype implementation and phantom measurements of
automated breathing signal-guided 4D CT. Med Phys. 2020;47(6):2408-2412.
doi:https://doi.org/10.1002/mp.14106

13.

Szkitsak J, Werner R, Fernolendt S, et al. First clinical evaluation of breathing
controlled four-dimensional computed tomography imaging. Phys imaging Radiat
Oncol. 2021;20:56-61.

14.

Castillo SJ, Castillo R, Castillo E, et al. Evaluation of 4D CT acquisition methods
designed to reduce artifacts. J Appl Clin Med Phys. 2015;16(2):4949.

15.

Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour
segmentation of anatomical structures: significantly improved efficiency and
reliability. Neuroimage. 2006;31(3):1116-1128.
doi:10.1016/j.neuroimage.2006.01.015

16.

Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing
platform for the Quantitative Imaging Network. Magn Reson Imaging.
2012;30(9):1323-1341. doi:10.1016/j.mri.2012.05.001

17.

Yamamoto T, Kabus S, Lorenz C, et al. 4D CT lung ventilation images are
85

affected by the 4D CT sorting method. Med Phys. 2013;40(10):101907.
doi:10.1118/1.4820538
18.

Sawant A, Yamamoto T, Cai J. Treatment planning based on lung functional
avoidance is not ready for clinical deployment. Med Phys. 2018;45(6):2353-2356.
doi:10.1002/mp.12881

19.

Young HM, Park CK, Chau O-W, Lee T-Y, Gaede S. Technical Note: Volumetric
computed tomography for radiotherapy simulation and treatment planning. J Appl
Clin Med Phys. July 2021. doi:10.1002/acm2.13336

86

CHAPTER 4

4

Simultaneous Ventilation and Perfusion Using Computed
Tomography: Validation of a Novel Lung Imaging
Technique

We developed a novel pipeline to simultaneously image ventilation (V), perfusion (Q), and
V/Q ratio on a volumetric CT scanner. Two pigs underwent this protocol, and Xe-enhanced
CT ventilation and PET perfusion imaging for validation, demonstrating significant
correlation between the established methods and our novel technique. Two NSCLC
patients underwent the V/Q imaging protocol before and six weeks after radiation therapy,
demonstrating its feasibility in this patient population and its sensitivity to functional
changes after radiation therapy.
The contents of this chapter are in preparation for submission to the journal Medical
Physics by: HM Young, F Su, TY Lee, and S Gaede.

4.1 Introduction
Early trials incorporating CT-based functional lung avoidance in radiation therapy have
shown positive results, suggesting the strong potential of this method to substantially
reduce radiation toxicity in NSCLC. Studies to validate CT-based ventilation imaging
(CTVI) against established methods have shown weak to moderate correlation. There are
various potential reasons why correlation is not stronger. First, past validation studies
comparing CTVI against “gold standard” measurements of lung ventilation, including
Galligas PET1–3, Technegas SPECT4, 3He or 129Xe MRI5–7, and Xe-CT8–10 required cross
modality deformable image registration. Patients are often imaged in a different position,
under different breathing conditions (free breathing versus deep inhalation),7 and on
different days. Second, CTVI methods using 4D-CT imaging also require registration of
extreme phases of respiration and, therefore, rely on accurate deformable image
registration algorithms. Also, 4D-CT is prone to motion artifacts and, therefore, may lead
to inaccurate measures of ventilation11. Finally, ventilation is only one measure of lung
function. Perfusion is also critical to gas exchange, and as such may be an equally important
imaging marker of function12,13.
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In the assessment of lung function before and/or after radiation therapy, there have been
few studies which include both ventilation and perfusion. As a result, it is difficult to say
with confidence whether ventilation, perfusion, or the ventilation-perfusion ratio (V/Q) is
a more reliable marker for tissues that should be preferentially spared from radiation to
reduce the risk of radiation pneumonitis. One study showed that perfusion more effectively
predicted CT density changes after radiation12, but this has not yet been studied in relation
to patient outcomes.
To date, ventilation/perfusion ratio (V/Q) imaging has mostly been performed using
nuclear imaging techniques; SPECT and PET14,15. These methods are more expensive and
less widely accessible to radiation oncology patients. The development of a method which
images both ventilation and perfusion, simultaneously, and can be easily incorporated
directly into CT based radiation treatment planning will enable research into both measures
of lung function and how to optimally define regions of high function for preservation.
Volumetric CT (vCT) scanners have recently been introduced to diagnostic imaging
departments world-wide and offer whole organ dynamic imaging capabilities16. VCT can
image up to 16 cm axial field-of-view (aFOV) and rotate as fast as 0.28 s per revolution.
VCT offers a well-established method for measuring cardiac perfusion that is typically
acquired under breath-hold conditions.
Volumetric CT scanners are not yet widely used in radiation oncology in North America,
but as their prevalence grows in radiology, increased used in radiation oncology may
follow. Volumetric 4D-CT has the potential to reduce or eliminate motion artifacts17 and
therefore provide more accurate simulation for radiation therapy and more accurate
measures of ventilation. In addition, its wide aFOV enables dynamic perfusion imaging
across a larger volume than was possible with previous generations of CT scanners. It is
therefore possible to use vCT generate simultaneous 3-dimensional maps of ventilation (V)
and perfusion (Q), and V/Q ratio.
The purpose of this study is two-fold. First, we describe and validate a novel protocol to
simultaneously image ventilation and perfusion in a dynamic contrast-enhanced CT scan
using a volumetric CT scanner using a pre-clinical porcine model. Ventilation imaging will
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be validated against xenon-enhanced CT ventilation, acquired during the same CT
scanning session, and perfusion imaging will be validated against

68

Ga labelled

macroaggregated albumin (MAA) PET perfusion imaging, acquired in a PET/CT scanning
session performed immediately following vCT. Second, applications of 4D-CT ventilation
imaging will be considered in two Stage III NSCLC patients where V, Q, and V/Q ratio
will be compared at baseline and at 6-weeks post radiotherapy.

4.2 Materials and Methods
4.2.1

Porcine Study

Two pigs were imaged for this study under anesthetic and mechanical ventilation using a
Harvard large animal ventilator. The animals were ventilated at a rate of 20 breaths/minute
and a breathing volume of 7-15 mL/kg of body weight. One pig was imaged at a single
timepoint at a weight of 37 kg and the second pig was imaged at three timepoints (week 0,
33 kg; week 2, 35 kg; week 7, 63 kg).
4.2.1.1 Dynamic Contrast-Enhanced CT Acquisition
The animals were imaged on a GE Revolution 256-slice volumetric CT scanner (GE
Healthcare, Milwaukee, USA). The image acquisition details are shown in Table 4-1.
Table 4-1 Scan parameters for all CT image acquisitions
Subject Mode Rotation aFOV
Voltage Current
Speed [s] [mm]
[kV]
[mA]

Scan
time [s]

pig

cine

0.5

160

80

120

60

NSCLC
patient

cine

0.28

160

100

100

40-60

The animals were imaged in a supine position with their forearms raised. At the beginning
of the study, the animals were breathing medical air. The Xe-enhanced CT scan was
performed first, as Xe gas is washed out more quickly than an injected iodine-based
contrast agent. An apparatus built in-house was used to switch between medical air and the
Xe source during imaging. The experimental setup is shown in Figure 4-1. A reservoir bag
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was filled with 99.999% purity xenon gas; for the first two studies, a 2 L bag was used. For
the final two studies, a 4 L bag was used because the Xe was being diluted with medical
air in the tubing before being inhaled. At the beginning of the scan, the animal was
breathing in medical air through the ventilator. After 5 seconds passed, a single switch was
turned to shut off the ventilator connection to the medical air tank, and to open the
connection to the Xe bag. The animal inhaled the Xe gas in multiple breaths, with the
concentration in the lungs increasing over time. When the Xe bag was empty, the switch
was returned to close the Xe connection to the ventilator and restore the ventilator access
to medical air. The concentration of Xe passing from the ventilator to the animal was
measured using a Xe/Oxygen concentration monitor and the peak concentration was
recorded.

Figure 4-1 Experimental setup used for Xe-enhanced ventilation imaging.
A fixed volume of Xe was stored in one reservoir bag (yellow) and medical air flowed
through the second bag (green). An in-house constructed mechanism (pink) was used to
switch the ventilator source between these bags. The gas was pulled from one of these bags
through the ventilator and passed through a Xe concentration monitor before being inhaled
by the anesthetized pig.
A five-minute wait period was used between the Xe-enhanced CT scan and the
simultaneous ventilation-perfusion scan to ensure wash-out of the Xe gas. The V/Q scan
was acquired with the same parameters as used for the Xe scan, shown above and in Table
4-1. The animal was breathing medical air for the duration of this scan. 10 seconds after
the image acquisition started, a bolus injection of Isovue contrast was given. Images were
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reconstructed into 5 mm slices, with an in-plane resolution of 0.58 mm x 0.58 mm, and a
temporal resolution of 0.5 seconds.
4.2.1.2 68Ga MAA PET Acquisition
Immediately following CT imaging, the animal underwent PET-CT imaging on a GE
Discovery VCT PET-CT scanner in the same position as was used for CT imaging: supine
with the forearms raised. A slow helical CT image was acquired for attenuation correction
and for identifying the thoracic cavity. One vial of macroaggregated albumin (MAA)
(Jubilant DraxImage Inc. dba, Montreal Canada) was labelled with up to 200 MBq of Ga68 produced in a local cyclotron18. Up to 10 mL of labelled MAA was injected into the
animal and the dose syringe was assayed before and after the injection to determine the
activity injected. Immediately after injection, a ten-minute dynamic scan was acquired,
followed by two static five-minute scans. All images were reconstructed to 3.3 mm thick
slices with an in-plane resolution of 1 mm x 1 mm.
4.2.1.3 Perfusion Analysis
Deformable image registration was performed using Elastix to register all images in the
V/Q CT image series to the first image. The registration algorithm used b-spline
interpolation, and a normalized mutual information metric. The registered images were
loaded into a trial version of GE CT Perfusion software (GE Healthcare, Milwaukee) to
calculate blood flow using the Johnson-Wilson-Lee tracer-kinetic model19.
The first three minutes of the dynamic PET perfusion scan were also loaded into the trial
version of CT Perfusion software. Blood flow was calculated using the Johnson-WilsonLee tracer-kinetic model with a modified impulse residue function to account for the fact
that MAA arrests in the capillaries of the lung after injection.
4.2.1.4 Ventilation Analysis
An end-inhale and an end-exhale image were identified from the pre-contrast portion of
the V/Q scan after deformable image registration had been applied as explained above. A
lung volume mask was generated using a semi-automatic density-based method. Voxel91

wise specific ventilation was calculated within the lung mask from these images using
Equation 4-120 below, where HUin and HUex are the CT number of the voxel in the inhale
and exhale images, respectively:
Equation 4-1
𝑆𝑉 = 1000 ×

𝐻𝑈") − 𝐻𝑈%*
𝐻𝑈%* (1000 + 𝐻𝑈") )

In Equation 4-1 above, SV is specific ventilation, HUin and HUex are the CT numbers of
the voxel in the inhale and exhale images, respectively. From the Xe-enhanced scan, an
end-inhale image was identified form the pre-Xe baseline portion of the scan, and from the
time of peak Xe enhancement. These images were both non-rigidly registered to the
baseline V/Q image using Elastix, so both ventilation maps could be directly compared. A
map of ventilation was calculated within the same lung mask using Equation 4-2 below,
where HUPeakXe and HUBL represent the CT number of the voxel in the peak enhancement
and baseline images, respectively:
Equation 4-2
𝑋𝑒𝑉𝑒𝑛𝑡 = 𝐻𝑈5%'67% − 𝐻𝑈89
4.2.1.5 Statistical Analysis
To compare the V/Q SV maps to the Xe-enhanced ventilation maps, both were downsampled to 1 cm x 1 cm x 1 cm spatial resolution to minimize the impact of small
registration errors and image noise. Ventilation values were compared voxel-wise using
the Pearson correlation coefficient. Similarly, the perfusion maps were down sampled to a
5 mm x 5 mm x 5 mm spatial resolution. A smaller resolution was chosen because the CT
and PET images were not acquired on the same scanner, so the overlap of the two maps is
imperfect and fewer voxels are available for the calculation. Perfusion values were also
compared voxel-wise using the Pearson correlation coefficient.
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4.2.2

NSCLC Patient Study

Two patients with Stage III non-small cell lung cancer were imaged before and six weeks
after undergoing radiation therapy as part of the Radiation Induced Cardiac Toxicity- Lung
clinical trial (NCT03416972).
4.2.2.1 Patient Characteristics
Clinical characteristics of the two patients enrolled in the study are summarized in Table
4-2 below:
Table 4-2 Clinical characteristics of the patients who participated in the study.
Age (years)
Sex
Tumour Location
Staging
Radiation Dosing
Additional
Treatments

Patient 1
65
M
Upper left lobe
T3N2M0
60 Gy in 30 fx
concurrent carboplatin and
paclitaxel, then durvalumab
immunotherapy

Comorbidities

History of coronary artery
disease
Clinical Symptoms Increasing cough, shortness
After 1 year
of breath, hypotension

Patient 2
63
M
Upper left lobe
T4N2M0
60 Gy in 30 fx with PETdelineated sub-volume
simultaneously boosted to 77 Gy
concurrent cisplatin and
vinblastine, then durvalumab
immunotherapy
None

4.2.2.2 Image Acquisition
The patients were imaged on a GE Revolution volumetric CT scanner with the acquisition
details shown in Table 4-1. Image reconstruction was cardiac-gated for the purposes of the
clinical trial, which led to some variation in total scan time and the time at which contrast
was injected. An iodine-based contrast was administered approximately 10 seconds after
the beginning of the dynamic scan. Images were reconstructed into 5 mm slices, with an
in-plane resolution of 0.9 mm x 0.9 mm and a temporal resolution of 0.3 seconds.
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4.2.2.3 Perfusion and Ventilation
Deformable image registration was performed to register all images in the CT image series
to the first image as described above. Blood flow maps were calculated using a trial version
of GE CT Perfusion software (GE Healthcare, Milwake). Specific ventilation maps were
calculated using the same method described in the animal study above.
4.2.2.4 V/Q Ratio Maps
The ventilation and perfusion maps were already co-registered as they came from the same
registered image set. The ventilation (V) and perfusion (Q) maps were both normalized to
the 99th percentile of the image distribution and a V/Q map was calculated as a voxel-wise
ratio of the two maps.
4.2.2.5 Interpretation of NSCLC Patient Imaging
The patient results were interpreted qualitatively with a focus on changes from baseline to
follow-up imaging after radiation therapy.

4.3 Results
4.3.1

Porcine Study

4.3.1.1 Perfusion
For all imaging sessions, the MAA was successfully labelled with 68Ga21 and both contrastenhanced imaging sessions were performed successfully. For all imaging sessions a
moderate voxel-wise correlation was observed between the V/Q CT perfusion scan and the
PET perfusion scan (r = 0.24-0.54, p < 0.001 for all). Qualitatively, patterns of perfusion
were consistent between the two scan types, with higher perfusion in the posterior lung,
and lower perfusion in the anterior. These results are shown in Figure 4-2.
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Figure 4-2 Voxel-wise comparison of CT and PET perfusion imaging.
Representative image samples from each scan are shown (W = 220, L = 110 HU) on the
left. In the right column, voxel-wise comparison of CT perfusion compared to PET
perfusion is shown. The two methods were significantly correlated in all cases (r = 0.24 0.54, p < 0.001 for all).
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4.3.1.2 Ventilation
For all imaging sessions, acquisition of both V/Q and Xe-enhanced ventilation were
performed successfully. For the first two imaging sessions (pig 1, and pig 2 week 0) when
only 2 L of Xe was used, the CT V/Q ventilation images were not significantly correlated
to the Xe-enhanced ventilation images. In these cases, the Xe signal measured in the lungs
was lower, and the qualitative distribution of the signal was different than expected, with
a low Xe signal in the posterior regions of the lungs. In the second two imaging sessions
(pig 2, week 2 and week 7) when 4 L of Xe was used, V/Q and Xe-enhanced ventilation
images were significantly correlated. In study 3, the V/Q ventilation and Xe ventilation
were moderately correlated (r = 0.66, p < 0.0001), and in study 4 they were weakly
correlated (r = 0.12, p = 0.0001). Qualitatively, the Xe signal took on the expected
distribution with higher ventilation in the posterior lung. These results are shown in Figure
4-3.
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Figure 4-3 Voxel-wise comparison of V/Q and Xe-enhanced CT ventilation imaging.
Representative image samples from each scan are shown (V/Q SV: W = 1.5, L = 0.5; Xeventilation: W = 120, L = 60 HU) on the left. In the right column, voxel-wise comparison
of SV compared to Xe-enhanced ventilation is shown. For the first two sessions, 2 L of Xe
was used and the two ventilation measures are not significantly correlated. However, for
the second two sessions, 4 L of Xe was used and the V/Q SV maps were significantly
correlated to the Xe-enhanced maps (r = 0.66, p < 0.001; r = 0.12, p = 0.0001).
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4.3.2

NSCLC Patient Study

In both patients, the V/Q imaging procedure was well tolerated. In patient 1, both
ventilation and perfusion decreased in the left lung after radiation therapy, as shown in
Figure 4-4. The blood flow map shows that the patient’s tumour has heterogeneous
perfusion before treatment. In patient 2, ventilation decreased in the left lung after radiation
therapy, but perfusion increased, as shown in Figure 4-5. This patient exhibited low
perfusion and V/Q mismatch in the left lung before treatment, suggesting the tumour may
have been restricting blood flow to the area. This patient showed signs of emphysema in
the right lung in an area of low attenuation. In this region, the ventilation map appeared
normal, but the blood flow map showed very low blood flow. As a result, this region
appeared clearly as V/Q mismatch in V/Q imaging.

Figure 4-4 Representative slices from V/Q imaging at baseline and 6 weeks after
radiotherapy in patient 1.
The averaged CT image (left) is provided for anatomical reference. Specific ventilation
maps (second column) indicated decreased ventilation in the left lung after treatment.
Blood flow maps (third column) indicated heterogeneous tumour perfusion at baseline
(white arrows) and decreased blood flow in the left lung at follow-up. V/Q maps (right)
indicated regions of V/Q mismatch (yellow) or reversed mismatch (blue).
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Figure 4-5 Representative slices from V/Q imaging at baseline and 6 weeks after
radiotherapy in patient 2.
The averaged CT image (left) is provided for anatomical reference. Specific ventilation
maps (second column) showed reduced ventilation in the left lung after treatment. Blood
flow maps (third column) showed low tumour perfusion at baseline (white arrows) and
increased blood flow in the irradiated lung after treatment. V/Q maps (right) indicated
regions of V/Q mismatch (yellow) or reversed mismatch (blue). A region of emphysema
(red arrows) appeared normal in the SV map but had low blood flow and appeared as V/Q
mismatch.

4.4 Discussion
To the authors’ knowledge, this is the first study to implement CT-based ventilation,
perfusion, and V/Q imaging before and after radiation therapy in NSCLC. This study
demonstrated the feasibility of this technique and demonstrated the method’s sensitivity to
changes after radiation therapy. While further study is needed to determine the sensitivity
of the method to clinically relevant outcomes, these results are promising.
These results indicate two particularly interesting phenomenon that warrant further
investigation. First, blood flow imaging in patient 1 indicated heterogeneous tumour blood
flow at baseline, and low tumour blood flow in patient 2. Tumour blood flow has known
effects on radiosensitivity22, and the ability of this imaging technique to generate
biomarkers predictive of patient outcomes should be further studied. In addition, patient
2’s baseline imaging demonstrates the value of collecting ventilation, perfusion, and V/Q
imaging simultaneously. There appears to be an emphysematous region with normal99

appearing ventilation. This is not unusual, as air may easily reach the region and inflate the
lung tissue even if it has suffered degradation. However, the tissue loss was clearly seen in
blood-flow imaging as a region of low blood flow, and in the V/Q map as a region of
mismatch. There have been few studies comparing the ventilation and perfusion for
creating functional avoidance structures and the outcomes of using each one or both
together13. More work is needed in this area to ensure that the imaging used in future
clinical trials is both easily implemented in a clinical setting, and highly sensitive to
clinically relevant changes.
There have been several studies performed previously which have attempted to validate
CT ventilation imaging measures1. Reaching a consensus on the best approach for this
technique has been challenging as there are many variables to consider including whether
the scan was performed under free-breathing or breath-hold conditions, the type of
deformable image registration used, the ventilation calculation used, and the “gold
standard” to which the CT method is compared. Recent review papers report that validation
studies have yielded highly variable results, likely due to these many variables1,23,24. In this
study, were able to reduce two of these variables by ensuring that all imaging was
performed under free-breathing conditions, and both ventilation methods were performed
back-to-back on the same scanner, so the animal did not move between images.
In this study, two of the Xe-enhanced CT images were noticeably different than was
expected from previous studies, which demonstrated that ventilation was higher in the
posterior regions of the lung, and lower in the anterior when the animal is positioned
supine25–27, as is also observed in humans. In the first two studies performed, when only 2
L of Xe was used in our ventilation system, this pattern was not clearly present, and our
novel V/Q method did not correlate significantly to the Xe-measured ventilation. However,
in the second two studies, when 4 L of Xe was used, the Xe ventilation maps appeared
qualitatively as expected, and correlated significantly with our method. This suggests that,
using the method outlined in this paper, 2 L of Xe is insufficient to image ventilation in a
30-60 kg pig and that 4 L is more appropriate.
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The voxel-wise correlations measured between CT and PET perfusion methods, and
between V/Q and Xe-enhanced ventilation methods were moderate, which is in alignment
with comparable previous studies2,24. The mostly closely related study compared Jacobianbased CT ventilation measurements to Xe-enhanced CT ventilation8. This study used
voxels within a rectangular region of interest on a chosen sagittal slice for comparison of
the two methods. This study found a strong correlation between the novel Jacobian method
and the Xe-enhanced method using these selected voxels, but it is unknown how a voxelwise comparison through the entire lung volume would compare. Our validation study
likely performed equally well, as previous studies have shown that voxel-wise correlation
improves with the size of the voxels used6, and a whole-lung method is susceptible to errors
due to registration or from partial-volume effects near the lung boundary, so are likely to
have reduced total correlation measures.
There are several limitations to our validation method. Firstly, all CT imaging was
performed with 0.5 s temporal resolution, so respiratory motion causes minimal blurring
in the image, while the PET perfusion imaging had a minimum temporal resolution of 5 s,
so the images are blurred from respiratory motion. The measured perfusion values,
especially in the inferior lungs, should therefore not be expected to perfectly correlate
between the two modalities. Secondly, the pigs in the study were healthy, so they do not
represent the heterogeneous ventilation and perfusion that would be present in most clinical
applications of this technique. Lastly, the sample size for this study is small, with only two
studies performed with an adequate dose of Xe. Further research may strengthen the
findings shown here.
The patient imaging included in this study demonstrates several ways that CT V/Q imaging
may impact clinical care. These include baseline tumour perfusion, which may suggest
hypoxia, and baseline ventilation and perfusion which may indicate the susceptibility of
surrounding lung tissue to radiation-induced toxicity. Follow-up imaging after treatment
can show changes in blood flow due to reperfusion or inflammation, and changes in
ventilation due to decreased airway obstruction or to inflammation. Importantly, this
protocol can be easily applied at any follow-up timepoint when the patient would normally
undergo CT imaging, so it can be more easily integrated in research or clinical practice
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than MRI or nuclear imaging. This study showed the feasibility of a novel protocol to
derive ventilation, perfusion, and V/Q maps in a single dynamic CT scan and the results
shown here highlight the potential clinical impact of this method.

4.5 Conclusion
In this study, the feasibility of a novel imaging acquisition and processing pipeline for CTbased ventilation, perfusion, and V/Q imaging was demonstrated. The technique was
applied in 4 scans of 2 pigs, along with Xe-enhanced CT ventilation and PET perfusion,
and demonstrated weak to moderate correlation with these established measures. Finally,
the technique was used to generate comprehensive maps of lung function in two patients
with NSCLC before and after undergoing radiation therapy and was sensitive to postradiotherapy functional changes. This technique has exciting possible applications in
clinical practice for better understanding the lung function of patients, and in research for
studies of functional avoidance, treatment response, and other radiobiology research
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CHAPTER 5

5

CONCLUSIONS AND FUTURE DIRECTIONS

In this final chapter, a summary of the important findings and conclusions of Chapters 24 are provided, as well as a discussion of the limitations of each chapter. Finally, future
studies to build on this work are outlined.

5.1 Overview and Research Questions
Volumetric CT scanners show great promise for both clinical and research applications in
radiation oncology, especially in thoracic cancers such as non-small cell lung cancer
(NSCLC). First, it was important to validate that the techniques used to reduce cone-beam
artifacts in these scanners are sufficient to produce accurate CT numbers for CT simulation
and radiation treatment planning. The first research objective in this thesis is to determine
if volumetric CT scanners are suitable for use in radiotherapy simulation and treatment
planning.
Next, I demonstrated how a volumetric CT scanner may be used to improve 4D-CT
imaging of NSCLC. The second research objective was to determine if a 4D-CT protocol
using a volumetric CT scanner reduces visible motion artifacts in patients with NSCLC
and if so, if this reduction in motion artifacts significantly improves contouring accuracy.
The final objective of this thesis was to develop and demonstrate the feasibility of a method
to image lung ventilation, perfusion, and ventilation-perfusion ratio in a single volumetric
CT scanning protocol.

5.2 Summary and Conclusions
In Chapter 2 I imaged a Catphan phantom (The Phantom Laboratory, Salem, NY, USA) in
a volumetric CT scanner using a range of aFOV values from the narrowest (40 mm) to the
widest (160 mm). I assessed quality metrics including linearity, contrast-to-noise ratio
(CNR), and uniformity for every image set, and compared them as a function of aFOV.
The CT numbers of the highest density inserts were underestimated, but this could be
corrected using an appropriate relative electron density (RED) curve. The RED curves I
created from this data varied slightly as a function of aFOV, although the changes are not
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likely to significantly impact dosimetric calculations. This concern can be eliminated
entirely with the use of a separate RED curve for each aFOV or by using an average RED
curve. From these results, I concluded that there are no clinically significant differences
between narrow and wide aFOV imaging on this scanner, and it is, therefore, suitable for
radiation therapy simulation and treatment planning of many patients.
In Chapter 3 of this thesis, I outline the development of a novel method to reconstruct
volumetric 4D-CT (v4D-CT). I compared the resulting datasets to clinical 4D-CT by
imaging a motion phantom and four patients with NCSLC on both scanners. I re-sorted the
v4D-CT image data, and discarded some, to simulate a conventional step-and-shoot
acquisition with a clinical CT scanner (sim4D-CT). I qualitatively compared images from
these three datasets for changes in visible motion artifacts and in both the phantom and
patient images there was a clear reduction in motion artifacts using v4D-CT. I contoured a
spherical target in the motion phantom and patient organs at risk (OARs) on each phase of
each scan type. The mean Hausdorff distance between v4D-CT and clinical 4D-CT
contours was significantly correlated to phase, suggesting that motion artifacts contributed
to this difference. From this work I concluded that v4D-CT significantly reduces visible
motion artifacts and significantly improves target and OAR contouring, which may impact
patient outcomes.
In Chapter 4 of this thesis, I describe the development of a novel method to image
ventilation (V), perfusion (Q), and the ventilation-perfusion ratio (V/Q) in a single dynamic
contrast-enhanced CT scan. I performed an animal study to validate these methods against
established Xe-enhanced CT ventilation and

68

Ga labelled MAA PET perfusion and

imaged two patients with Stage III NSCLC before and six weeks after radiation therapy.
This novel imaging pipeline was feasible in the patient population of interest, and changes
in V and Q were detected in both patients six weeks after radiotherapy. The validation
results indicated moderate and significant voxel-wise correlation between perfusion
images from the V/Q scan and PET perfusion images (r = 0.24-0.54, p < 0.0001 for all).
The V/Q scan ventilation map and the Xe ventilation map were also significantly correlatd
for the two studies in which 4 L of Xe was used (r = 0.66, p < 0.0001; r = 0.12, p = 0.0001).
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In summary, I demonstrated the suitability of vCT for radiation therapy simulation and
treatment planning using a Catphan imaging study. I then showed that v4D-CT effectively
eliminated visible respiratory motion artifacts which plague current clinical 4D-CT
methods and improved contours of a spherical target and OARs, which may impact patient
outcomes. Finally, I developed a method to generate images of ventilation, perfusion, and
V/Q in a single volumetric CT scan and demonstrated the feasibility and sensitivity of this
method in patients with NSCLC before and after radiation therapy.

5.3 Limitations
In this section, limitations from Chapters 2-4 will be summarized. It should be noted that
the study-specific limitations are also presented in the Discussion section of each Chapter.
The primary limitation of Chapter 2 is that only Catphan phantom images were analyzed.
Additional studies using an anthropomorphic phantom or human subjects may confirm that
the findings in this study hold for all imaging applications. In addition, the volumetric CT
scanner used in this study has a smaller bore size (diameter 80 cm) than most modern CT
simulators. This small bore limits its use for imaging large patients or patients who require
large positioning and immobilization equipment. As the prevalence of these scanners
increases over time, development of a wide-bore model would facilitate increased use in
radiation oncology settings
In Chapter 3, the limitation of the narrow bore size of current volumetric CT scanners also
applies. Another limitation of this study is the fact that the sim4D-CT and clinical 4D-CT
scans could not be exactly compared. The sim4D-CT data was simulated with an aFOV of
20 mm, while the clinical 4D-CT data was acquired with an aFOV of 24 mm. In addition,
the sim 4D-CT images were acquired with a faster rotation time (0.28s/rotation) than the
clinical scans (0.5s/rotation), so the blur in the sim4D-CT images was reduced. These
limitations are likely the reason the contour comparisons between v4D-CT and sim4D-CT
images were not significant. However, the sim4D-CT images still reproduced visually
obvious motion artifacts, confirming that from the exact same imaging data, a wide aFOV
is the cause of motion artifact reduction.
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The primary limitation in Chapter 4 is the small number of patients and animals imaged.
While the NSCLC patient imaging clearly demonstrates the feasibility of the technique,
more imaging is required to demonstrate the sensitivity of the technique to clinically
relevant changes in functional images. While the validation performed for this thesis has
already demonstrated significant correlation of ventilation and perfusion imaging from our
novel method with established methods, a larger study may strengthen these findings.

5.4 Future Directions
5.4.1

Validation of Ventilation-Perfusion Method

The results shown in Chapter 4 of this thesis demonstrate the feasibility of generating
ventilation and perfusion imaging in a single dynamic contrast-enhanced CT scan. This
chapter also includes results which show that this method is sensitive to changes in
ventilation and perfusion after conventionally fractionated radiation therapy for stage III
non-small cell lung cancer in a sample of two patients. A small validation study was also
performed with positive results. Building off the findings in this thesis, a larger validation
study using the same methods outlined in Chapter 4 may provide stronger evidence to
support the translation of this work into other research applications.
Alternatively, to eliminate dependence on Xe for the study, ventilation imaging using
Galligas PET imaging may be considered1, as it is another established method of imaging
ventilation and has been used in validation studies of CTVI methods2,3. If this method is
used, great care must be taken to ensure that deposition of the tracer in the large airways is
excluded from the image, so it does not negatively impact the comparison to our CTVI
method.

5.4.2

Future Clinical Study

The imaging pipeline developed in Chapter 4 has many potential research applications. It
is particularly well-suited to address unanswered questions about which lung imaging
metrics are the best predictors of patient outcomes such as radiation pneumonitis. There
are already ongoing clinical trials using ventilation or perfusion metrics to generate
functional avoidance volumes4, and early results are positive5. However, there has been
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little work done to compare the effectiveness of different functional imaging metrics so it
is not known which methods will perform best clinically. One animal study suggested that
perfusion measurements were more predictive of increased lung density at follow-up than
ventilation6, but the clinical impact of this difference is not yet known.
Functional lung imaging may also provide important information for research involving
other treatments for NSCLC including surgery, chemotherapy, and more recently,
immunotherapy. Surgery is a local treatment, so lung function before surgery is important
when determining if surgery is the best course of treatment. Global measures of lung
function such as spirometry and the diffusing capacity of the lungs for carbon monoxide
(DLCO) are often used, but research in other lung diseases suggests that the spatial
information provided by imaging can help to predict patient outcomes7. Chemotherapy and
immunotherapy are often used in conjunction with radiation therapy, and combined
therapies are known to increase the risk of radiation pneumonitis8,9. More research is
needed to determine which patients will develop unacceptable toxicity, and how it might
be prevented.
In a study being prepared for ethics submission, we aim to use the technique outlined in
Chapter 4 to image ventilation, perfusion, and V/Q ratio in patients with Stage I-III NSCLC
before and after their treatment. This treatment may include surgery, chemotherapy,
immunotherapy, or radiation therapy. This study will address the following research
questions:
1) Does the volume of total lung, ventilated lung, perfused lung, or V/Q matched lung
receiving over 20 Gy predict the risk of pneumonitis?
2) Are there significant differences in the changes in ventilation, perfusion, or V/Q
ratio after therapy for patients undergoing single modality treatment, chemoradiation, or chemo-radiation followed by immunotherapy?
3) Do changes in functional imaging metrics at 6 weeks after therapy predict toxicity
present at 6 months or 1 year following treatment?
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5.5 Significance and Impact
NSCLC remains the leading cause of cancer deaths in Canada10, and potentially severe
treatment toxicities often prevent the use of higher radiation doses or otherwise more
aggressive treatment plans. Currently, approximately 30% of patients who undergo
radiation therapy experience radiation-induced lung injury (RILI)11. Limitations in imaging
have contributed to these problems; 4D-CT motion artifacts have been shown to be related
to reduced local control in liver cancer12. Developments in lung imaging, including
functional imaging for functional avoidance treatment planning, show promise for
reducing the risks of RILI13.
In this thesis, I explore methods to exploit the benefits of volumetric (or area-detector) CT
scanners to improve anatomical and functional imaging used in clinical care and research
of NSCLC. Volumetric CT scanners are increasing in use worldwide and will likely be
used increasingly in radiation oncology settings. This thesis sets the foundation for how
these scanners can be used in radiation oncology settings to significantly improve patient
care. In addition, there are innumerable research opportunities created by the ability to
image lung function using CT in a radiation oncology setting, as explained in section 5.4.
In this thesis, I demonstrated that volumetric CT scanners are suitable for CT simulation
and radiation treatment planning. I then demonstrated how the application of volumetric
4D-CT can greatly reduce motion artifacts and uncertainties in target and OAR contouring,
which may contribute to improved patient outcomes. Finally, I developed a protocol to
simultaneously image lung ventilation, perfusion, and V/Q ratio. I demonstrated how new
imaging protocols using volumetric CT advance both anatomical and functional lung
imaging in ways that can impact clinical care and provide new opportunities for clinical
research into lung function in patients with thoracic cancers.
The work in this thesis has many applications outside of NSCLC, including small-cell lung
cancer, esophageal cancer, breast cancer, and mediastinal lymphomas. These cancers are
all treated with high curative-intent doses, and RILI is a risk in all these patient cohorts14–
16

. Therefore, more accurate and detailed structural and functional lung imaging may be of

benefit in all these cases to reduce treatment toxicity. This work has may potential
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applications in research on radiation biology, functional lung avoidance, treatment
response research and more. Most importantly, the novel imaging methods explored in this
thesis can be easily implemented using any volumetric or area-detector CT scanner. As this
type of scanner becomes more commonplace in hospitals and cancer clinics, this research
may facilitate improvements in routine clinical imaging, and the use of validated functional
imaging biomarkers to improve patient outcomes.
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Supervisor: Dr. Robert Stodilka
2018-present

University of Western Ontario, London, Ontario
Graduate Research Assistant, PhD Candidate
Department of Medical Biophysics, University of Western Ontario
Supervisor: Dr. Stewart Gaede

2016-2017

Robarts Research Institute, London, Ontario
Graduate Research Assistant, MSc Candidate
Department of Medical Biophysics, University of Western Ontario
Supervisor: Dr. Grace Parraga

2015-2016

University of Waterloo, Waterloo, Ontario
Undergraduate Research Assistant
Supervisor: Dr. Melanie Campbell
Project: ‘Polarization Properties of Amyloid Beta in the Retina in
an Animal Model of Alzheimer’s Disease’

Sept-Dec 2014,
May-Aug 2015

London Regional Cancer Program, London, Ontario
Undergraduate Co-op Student
Supervisors: Dr. Stewart Gaede, Dr. Slav Yartsev
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Sept 2013- April 2014 Northeast Cancer Centre
Sudbury, Ontario
Undergraduate Co-op Student
Supervisor: Dr. Daniel Provost
Jan-April 2013

SNOLAB
Lively, Ontario
Undergraduate Research Assistant
Supervisor: Dr. Chris Jillings
Honours and Awards
June 2021

Poster Presentation Award
Western University Department of Oncology Research Education
Day
Institutional

June 2019

Magna Cum Laude Presentation Award
London Imaging Discovery Day
Institutional

May 2019

Alexander Graham Bell Canada Graduate Scholarship
Doctoral (CGS D)
Natural Sciences and Engineering Research Council of Canada (
NSERC)
National ($105,000 over 3 years)

May 2019

Ontario Graduate Scholarship (declined)
Provincial ($15,000, 1 year)

July 2018

Lawson Internal Research Fund Studentship
Lawson Health Research Institute
Institutional ($15,000, 1 year)

September 2017

AC Groom Graduate Seminar Award
Department of Medical Biophysics, University of Western Ontario
Institutional ($500)

Publications
A Peer-Reviewed Journal Manuscripts (5)
1. HM Young, CK Park, OW Chau, TY Lee, and S Gaede. Technical Note:
Volumetric Computed Tomography for Radiotherapy Simulation and Treatment
Planning. J Appl Clin Med Phys. July 2021. doi:10.1002/acm2.13336
2. HM Young, F Guo, RL Eddy, GN Maksym, and G Parraga. Oscillometry and

Pulmonary MRI Measurements of Ventilation Heterogeneity in Obstructive Lung
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Disease: Relationship to Quality of Life and Disease Control. J Appl Physiol 125:
73–85, 2018. doi: https://doi.org/10.1152/japplphysiol.01031.2017.
3. HM Young, RL Eddy, and G Parraga. MRI and CT Lung Biomarkers: Towards an

In Vivo Understanding of Lung Biomechanics. Invited Review, Clinical
Biomechanics. 66: 107-122, 2019. doi: 10.1016/j.clinbiomech.2017.09.016.
4. E Lessard, HM Young, A Bhalla, D Pike, K Sheikh, DG McCormack, A Ouriadov

and G. Parraga. Pulmonary Magnetic Resonance Imaging Biomarkers of Regional
Airspace Enlargement in Alpha-1 Antitrypsin Deficiency. Acad Radiol, 24(11),
1402-1411. doi: 10.1016/j.acra.2017.05.008.
5. K Sheikh, A Bhalla, A Ouriadov, HM Young, CM Yamashita, TM Luu, S Katz and

G Parraga. Pulmonary magnetic resonance imaging biomarkers of lung structure and
function in adult survivors of bronchopulmonary dysplasia with COPD. Cogent
Medicine, 4(1), 1282033. doi: 10.1080/2331205X.2017.1282033
B Proffered Oral Presentations (16)
1.

HM Young, F Su, TY Lee and S Gaede. Feasibility of Simultaneous Whole-Lung
Ventilation-Perfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer.
Imaging Network Ontario Annual Meeting. March 24, 2022.

2.

HM Young, F Su, TY Lee and S Gaede. Simultaneous Whole- Lung VentilationPerfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer: A
Feasibility Study. Lung Function Imaging Workshop. August 19, 2021.

3.

HM Young, F Su, TY Lee and S Gaede. Simultaneous Whole- Lung VentilationPerfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer: A
Feasibility Study. American Association of Physicists in Medicine Annual Meeting.
July 25, 2021.

4.

HM Young, J Kempe, TY Lee and S Gaede. Evaluation of Motion Artifacts in 4DCT Simulated from Volumetric Dynamic CT in Non-Small Cell Lung Cancer
Patients. Canadian Organization of Medical Physicists Annual Scientific Meeting.
June 23, 2021.

5.

HM Young, F Su, TY Lee and S Gaede. Simultaneous Whole- Lung VentilationPerfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer: A
Feasibility Study. Great Lakes Chapter- American Association of Physicists in
Medicine Young Investigator Symposium. May 26, 2021.

6.

HM Young, TY Lee and S Gaede. Impact of Volumetric 4D-CT Motion Artifact
Reduction on Ventilation Imaging. Imaging Network Ontario Annual Meeting.
March 23, 2021.
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7.

O Chau, HM Young, K Burgers, TY Lee, FS Prato, G Wisenberg and S Gaede.
Multi-Modality Imaging Assessment of the Heart and Lungs Before and After Stage
III Non-Small Cell Cancer Radiotherapy. Imaging Network Ontario Annual
Meeting. March 23, 2021.

8.

HM Young*, O Chau*, K Burgers, TY Lee, FS Prato, G Wisenberg, S Gaede.
Multi-modality imaging of the cardio-pulmonary system in stage III non-small cell
lung cancer. Joint AAPM COMP Virtual Meeting, Ventilation Workshop. July 12,
2020.

9.

HM Young, TY Lee, S Gaede. Impact of Volumetric 4D-CT Motion Artifact
Reduction on Ventilation Imaging. Joint AAPM COMP Virtual Meeting,
Ventilation Workshop. July 12, 2020.

10. HM Young, TY Lee, S Gaede. Impact of Volumetric 4D-CT Motion Artifact

Reduction on Ventilation Imaging. Joint AAPM COMP Virtual Meeting. July 15,
2020.
11. HM Young, TY Lee, S Gaede. Respiratory Motion Characterization and Motion

Artefact Reduction Using Volumetric 4-Dimensional Computed Tomography.
American Association of Physicists in Medicine Annual Meeting. San Antonio
USA. July 14, 2019.
12. HM Young, TY Lee, S Gaede. Volumetric 4-dimensional computed tomography

for artefact reduction and respiratory motion characterization. London Imaging
Discovery Day. London, Canada. June 12, 2019.
13. HM Young, K Burgers, TY Lee, S Gaede. Simultaneous Ventilation and Perfusion

Imaging with Volumetric 4-Dimensional Computed Tomography. American
Association of Physicists in Medicine Annual Meeting, Ventilation Workshop.
Nashville USA July 29, 2018.
14. HM Young, F Guo, RL Eddy, GN Maksym, G Parraga. Pulmonary MRI

Measurements of Ventilation Heterogeneity in Obstructive Lung Disease:
Relationship to Oscillometry, Quality of Life and Disease Control. ISMRM 26th
Annual Meeting Paris, France June 2018.
15. HM Young, DPI Capaldi, K Sheikh, DG McCormack, CM Yamashita, and G

Parraga. Ultra-Short Echo Time MRI Quantification of Airspace Enlargement in
Bronchopulmonary Dysplasia and Alpha-1 Antitrypsin Deficiency: Parenchyma
Destruction, Air trapping or Both? 15th Annual Imaging Network Ontario
Symposium, London, Canada, March 15-16, 2017.
16. HM Young, M Mulligan, K Jordan, S Gaede. Patient-Specific QA of Respiratory-

Gated VMAT using a Programmable Cylindrical Respiratory Motion Insert for the
ArcCHECK™ Phantom. World Congress on Medical Physics and Biomedical
Engineering 2015, Toronto Canada, June 7-12, 2015.
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C Proffered Poster Presentations (23)
1.

HM Young, F Su, TY Lee and S Gaede. Simultaneous Whole- Lung VentilationPerfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer: A
Feasibility Study. Department of Oncology Research and Education Day. June 18,
2021

2.

O Chau*, HM Young*, K Burgers, TY Lee, FS Prato, G Wisenberg and S Gaede.
Multi-Modality Imaging Assessment of the Heart and Lungs Before and After Stage
III Non-Small Cell Lung Cancer Radiotherapy Department of Oncology Research
and Education Day. June 18, 2021

3.

HM Young, F Su, TY Lee and S Gaede. Simultaneous Whole- Lung VentilationPerfusion Imaging with Volumetric CT in Non-Small Cell Lung Cancer: A
Feasibility Study. London Health Research Day. May 11, 2021.

4.

HM Young*, O Chau*, K Burgers, TY Lee, FS Prato, G Wisenberg, S Gaede.
Multi-modality imaging of treatment response after stage III non-small cell lung
cancer radiotherapy. Joint AAPM COMP Virtual Meeting. July 2020.

5.

HM Young, TY Lee and S Gaede. Volumetric vs. Conventional 4-dimensional CT
in Non-Small Cell Lung Cancer Patients. Imaging Network Ontario Annual
Meeting. Toronto, Canada. March 27, 2020.

6. HM Young, TY Lee and S Gaede. Volumetric 4-dimensional Computed

Tomography for Reduction of Respiratory Motion Artefacts. Oncology Research
and Education Day 2019. London, Canada. June 14 2019.
7. HM Young, TY Lee and S Gaede. Volumetric 4-dimensional Computed

Tomography for Reduction of Respiratory Motion Artefacts. London Health
Research Day 2019. London Canada. April 30 2019.
8. HM Young, TY Lee, S Gaede. Motion Artefact Reduction Using Volumetric 4-

Dimensional Computed Tomography. Imaging Network of Ontario Annual
Meeting, London Canada. March 28-29 2019.
9. HM Young, J Kempe, TY Lee and S Gaede. Preliminary Study of Motion Artefact

Reduction in Volumetric 4-dimensional Computed Tomography. American
Association of Physicists in Medicine Annual Meeting, Nashville USA. July 29-02
2018.
10. HM Young, J Kempe, TY Lee and S Gaede. Preliminary Study of Motion Artefact

Reduction in Volumetric 4-dimensional Computed Tomography. UWO Department
of Oncology Research and Education Day, London, Canada, June 8 2018.
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11. RL Eddy, HM Young, A Kassay, DPI Capaldi, S Svenningsen, DG McCormack, G

Parraga. Contributions of Large Versus Small Airways to MRI Ventilation
Heterogeneity in Asthmatics. ISMRM 26th Annual Meeting Paris, France June 2018.
12. A Westcott, RL Eddy, DPI Capaldi, HM Young, DG McCormack, G Parraga.

Quantification of Hyperpolarized 3He MRI Ventilation Heterogeneity in
Asthmatics: Surface Area of Ventilation Clusters. ISMRM 26th Annual Meeting
Paris, France June 2018.
13. C Church, HM Young, G Parraga and GN Maksym. Improvements in Functional

Image Impedance Modelling of Asthmatic Lungs Using K-means Clustering. ATS
2018 International Conference San Diego, CA, May 18-23, 2018.
14. A Ouriadov, DPI Capaldi, HM Young, M Kirby, HO Coxson, DG McCormack and

G Parraga. Imaging Biomarkers of Emphysema in COPD and Alpha-1 Antitrypsin
Deficiency Patients using Accelerated 129Xe MRI. ATS 2018 International
Conference San Diego, CA, May 18-23, 2018.
15.

HM Young, F Guo, RL Eddy, C Church, G Maksym and G Parraga. Forced
oscillation technique and MRI predictions of airway reactance in moderate-severe
asthma. ERS International Congress, Milan, Italy, September 9-13 2017.

16. HM Young, DPI Capaldi, K Sheikh, DM McCormack, CM Yamashita, and G

Parraga. Quantifying Airspace Enlargement in Bronchopulmonary Dysplasia and
Alpha-1 Antitrypsin Deficiency Using Ultra-Short Echo Time MRI. Robarts
Research Retreat 2017. Robarts Research Institute, Western University June 20
2017.
17. A Bhalla, K Sheikh, HM Young, RL Eddy, DG McCormack, TM Luu, S Katz, G

Parraga. Asthma Phenotypes in Adult Survivors of Premature Birth Using
Functional Magnetic Resonance Imaging. ATS International Conference (2017).
18. Alexei Ouriadov, E Lessard, F Guo, HM Young, A Bhalla, M Kirby, H Coxson,

DG. McCormack and G Parraga. Biomarkers of Emphysema in COPD and Alpha-1
Antitrypsin Deficiency: 129Xe MRI Morphomics. ATS International Conference
(2017).
19. HM Young, DPI Capaldi, K Sheikh, DM McCormack, CM Yamashita, and G

Parraga. Ultra-Short Echo Time MRI Quantification of Airspace Enlargement in
Bronchopulmonary Dysplasia and Alpha-1 Antitrypsin Deficiency: Parenchyma
Destruction, Air trapping or Both?. ISMRM 25th Annual Meeting, 6799 (2017).
20. A Ouriadov, E Lessard, F Guo, HM Young, A Bhalla, DG McCormack, and G

Parraga. Accelerated Diffusion-weighted 129Xe MRI Morphometry of Emphysema
in COPD and Alpha-1 Antitrypsin Deficiency Patients. ISMRM 25th Annual
Meeting, 2664 (2017).
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21. HM Young, DPI Capaldi, K Sheikh, DM McCormack, CM Yamashita, and G

Parraga. Quantifying Airspace Enlargement in Bronchopulmonary Dysplasia and
Alpha-1 Antitrypsin Deficiency Using Ultra-Short Echo Time MRI. London Health
Research Day 2017. Schulich School of Medicine and Dentistry, Western
University March 28 2017.
22. A. Ouriadov, E. Lessard, F. Guo, HM. Young, A. Bhalla, D.G. McCormack and G.

Parraga. Accelerated Diffusion-weighted 129Xe MRI Morphometry of Emphysema.
Imaging Network of Ontario (ImNO), 15th Annual Imaging Network Ontario
Symposium, London, Canada, March 15-16, 2017.
23. S Gaede, HM Young, M Mulligan, K Jordan, A Programmable Moving Insert for

the ArcCHECKTM Phantom for Dose Verification of Respiratory-Gated VMAT.
American Association of Physicists in Medicine Annual Meeting 2015 Anaheim CA
Jul 12-16, 2015.
Committees and professional activities
Sept 2020 - present Biomedical Imaging Research Centre Student Subcommittee
Student Committee Member
Sept 2018 – Aug 2021 Western University CAMPEP Steering Committee
Student Representative
Sept 2018-June 2019 Medical Biophysics Graduate Student Association
Site Representative and Internal Communications Representative
Jan-Aug 2018

Medical Biophysics Graduate Council Working Group
Student Member

2017- 2019

Medical Biophysics Graduate Recruitment Committee
Student Member

2017 - 2018

Inspiring Young Women in STEM Conference 2018
Graduate Program Expo Planning Committee- Member

2013 - 2015

University of Waterloo
Undergraduate Student Representative
Department of Physics

Leadership, Volunteer, and Community Activities
2020-present
2015-2016

Medical Biophysics Academic Mentorship Program
Mentor, CAMPEP Advisor
Physics Interconnected, University of Waterloo
Mentor
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